TSS:Hg 3481.1

Basic information about the TSS

---

TSS ID: hg_3481.1 Species: human Chr: chr1		Start: 70222109 End: 70222126 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000486667.5 Distance: -386 GeneID: 9295 HGNC/MGI_ID: HGNC:10782 UniProt_ID:

Gene_name: serine and arginine rich splicing factor 11 Gene_symbol: SRSF11 Gene_synonyms: NET2 p54 Gene_source: HGNC:10782

TATA-Box annotation

---

Distance to TSS:	738
Nearest PromoterID:	NR_146810
Entrez ID:	9295
Nearest Unigene:	Hs.479693
Nearest Refseq:	NM_004768
Nearest Ensembl:	ENSG00000116754
Gene Name:	serine and arginine rich splicing factor 11
Gene Alias:	NET2|SFRS11|dJ677H15.2|p54
Gene Description:	serine and arginine rich splicing factor 11
Gene Type:	protein-coding
CpG%:	0.045
GC%:	0.40796
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SRSF11 p2@SRSF11 p3@SRSF11 p4@SRSF11 p5@SRSF11 p6@SRSF11 p7@SRSF11 p10@SRSF11
Sample		p1@SRSF11	p2@SRSF11	p3@SRSF11	p4@SRSF11	p5@SRSF11	p6@SRSF11	p7@SRSF11	p10@SRSF11
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	50.65	34.87	21.62	21.04	4.09	10.13	1.75	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	55.64	37.63	22.26	20.03	2.63	10.12	1.62	2.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	59.80	37.42	20.83	18.71	2.89	10.80	1.54	2.89
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	52.19	34.31	19.13	20.38	3.95	9.98	0.62	2.08
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	55.12	32.62	25.42	24.52	2.25	11.47	3.37	2.02
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	62.99	30.04	17.83	21.51	4.46	11.43	1.55	3.10
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	69.72	47.28	25.27	30.29	3.70	10.24	1.96	2.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	58.62	29.55	23.74	17.68	2.91	8.24	1.21	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	70.10	38.26	26.71	20.73	2.99	5.77	0.85	2.78
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	60.28	49.27	25.50	47.53	4.64	8.69	1.74	4.06
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	65.08	48.51	34.76	35.98	6.06	11.72	0.40	2.43
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	58.54	50.41	34.15	44.31	6.10	8.13	0.41	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	29.66	28.37	19.18	5.96	2.90	0.32	1.29	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.82	21.65	13.38	4.96	2.41	0.60	1.05	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.44	20.42	19.54	2.63	2.42	0.22	0.66	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	25.15	14.59	10.06	4.28	2.01	0.00	1.26	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	26.65	16.38	11.79	2.62	1.09	0.22	0.87	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	28.26	15.19	9.70	3.37	4.22	0.84	1.69	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	27.19	15.99	9.06	6.93	1.60	0.00	1.07	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	26.93	21.96	14.14	3.31	3.01	1.20	1.05	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	30.34	23.12	14.03	3.74	2.94	0.67	1.34	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	28.14	23.65	11.91	4.49	4.66	0.17	0.52	2.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	27.92	19.91	13.57	4.78	2.46	0.65	1.55	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.55	20.63	13.10	6.07	2.43	0.24	2.67	2.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	31.99	19.09	14.71	6.45	2.58	0.26	1.55	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	29.75	18.99	13.61	4.11	2.85	0.63	1.27	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.02	21.43	17.03	2.75	2.20	0.55	0.55	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	30.88	29.00	16.74	5.66	2.59	0.47	1.18	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	32.14	26.17	13.41	6.14	1.78	0.65	1.29	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	31.49	25.15	17.92	5.07	2.53	0.36	1.81	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	31.40	18.21	13.61	6.91	2.72	1.26	1.88	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.79	17.39	15.83	7.42	3.32	0.39	0.39	3.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	28.07	27.22	13.29	4.43	2.74	0.63	1.27	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	36.12	24.41	10.23	4.45	2.14	0.99	2.14	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	23.56	18.51	13.65	4.49	2.43	0.19	2.06	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	25.49	19.74	18.20	6.52	4.02	1.15	0.96	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	28.20	18.80	20.44	3.88	1.84	0.41	0.41	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	24.58	15.11	11.89	5.44	1.61	0.40	1.21	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	34.84	17.29	15.94	4.59	2.97	0.00	1.08	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	26.89	15.12	19.45	4.56	2.16	0.24	0.48	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	27.29	15.29	18.35	5.65	1.41	0.94	1.41	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	35.28	18.30	10.83	3.66	1.61	0.73	1.02	2.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.99	20.25	21.51	8.86	2.74	0.63	0.63	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	28.15	16.61	18.36	5.24	2.27	1.22	1.75	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	34.53	20.88	23.49	6.83	1.41	0.80	2.01	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	31.64	13.49	20.47	6.98	2.56	0.70	0.93	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	28.07	14.87	21.83	6.96	3.36	0.96	0.72	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	34.87	15.20	12.52	6.86	0.89	1.49	0.89	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	33.75	18.19	20.35	7.90	2.15	0.00	0.96	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	33.77	12.94	16.18	4.85	1.82	1.21	0.81	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	40.17	12.30	14.76	8.20	1.02	1.02	0.61	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	41.36	19.35	20.90	8.01	1.33	1.78	1.56	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	41.98	55.97	0.00	0.00	0.00	167.91	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	32.65	15.97	17.39	5.68	1.42	0.35	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	33.80	12.92	12.92	8.62	2.32	0.33	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	46.98	15.94	14.26	5.87	0.84	4.19	9.23	16.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	47.76	15.61	14.70	1.38	0.92	1.38	1.84	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	34.68	13.61	19.45	8.75	1.62	0.65	0.32	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	26.01	11.24	11.56	8.03	2.89	0.64	0.96	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	40.23	11.63	15.72	3.14	0.63	0.63	1.57	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	26.09	9.87	19.04	5.64	1.41	0.71	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	23.55	12.34	14.58	5.61	0.56	0.00	1.12	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	35.03	11.15	10.35	1.59	0.00	0.00	7.96	9.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	32.96	8.83	11.55	3.40	2.04	0.34	2.04	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	28.59	13.65	14.62	6.82	0.32	0.00	1.30	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	29.11	13.84	10.65	3.19	1.06	1.06	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	32.33	16.16	0.00	0.00	0.00	48.49	32.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	244.82	47.38	31.59	7.90	0.00	7.90	0.00	39.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	31.69	6.83	8.78	3.41	0.49	1.46	1.95	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	43.64	10.91	8.93	3.47	0.99	0.00	0.00	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	33.78	10.32	8.44	1.88	0.00	0.94	0.47	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	37.42	8.94	10.27	1.32	0.99	1.32	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	27.84	11.14	5.88	2.17	0.93	0.31	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	38.22	7.03	7.95	1.83	1.22	0.00	0.31	0.92
Adipocyte - breast, donor1	11376-118A8	39.44	17.42	6.81	2.53	0.63	3.96	0.00	0.32
Adipocyte - breast, donor2	11327-117E4	23.10	13.64	6.10	2.89	1.28	1.93	2.09	0.96
Adipocyte - omental, donor1	11473-119C6	38.80	18.19	7.63	3.94	1.15	2.54	0.64	1.02
Adipocyte - omental, donor2	11474-119C7	27.66	7.47	7.47	2.24	0.75	0.00	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	22.44	8.04	6.70	1.34	2.01	1.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	30.62	7.66	5.10	2.55	0.00	1.28	0.00	1.91
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	2.20	2.20	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	18.97	6.32	3.61	0.45	0.90	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	13.55	6.43	2.61	0.52	0.87	0.00	0.35	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	41.46	33.25	12.13	5.08	2.35	0.98	0.20	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	24.71	23.16	9.78	5.66	2.06	0.77	0.51	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	25.93	14.22	9.76	4.46	1.39	0.00	0.56	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	25.28	17.63	10.58	4.70	2.35	0.59	0.00	1.76
Adipocyte differentiation, day08, donor1	13020-139D5	41.18	26.30	13.03	4.91	2.65	1.37	0.24	0.64
Adipocyte differentiation, day08, donor2	13023-139D8	30.02	15.49	10.97	3.87	1.29	0.32	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	28.79	14.40	6.93	3.20	1.07	0.00	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	25.04	13.35	11.13	2.23	0.56	2.23	0.00	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	17.05	14.14	4.57	1.66	2.08	0.00	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	23.36	15.07	7.28	1.76	2.01	0.50	1.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	21.60	11.78	10.47	1.64	0.33	0.98	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	20.10	9.13	7.31	2.44	1.52	0.30	0.61	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	9.50	4.64	3.31	0.88	0.00	0.44	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	7.17	0.72	2.15	1.43	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	0.00	1.20	0.00	0.00	0.00	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	20.15	10.79	2.88	1.80	0.54	0.72	0.18	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	6.69	3.35	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	8.63	4.73	2.67	1.03	0.62	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	38.22	13.16	3.55	1.03	0.46	1.14	0.34	0.23
Anulus Pulposus Cell, donor2	11463-119B5	18.61	3.92	3.92	0.98	0.49	0.73	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	20.22	10.33	3.59	0.90	1.80	1.35	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	25.61	3.04	4.34	1.30	0.00	1.74	1.74	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	2.14	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	28.40	8.67	5.08	1.20	1.49	1.20	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	20.23	3.79	5.06	6.32	0.00	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	3.30	5.28	1.98	0.66	1.98	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	21.44	3.57	5.52	2.92	0.32	1.30	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.73	7.77	3.40	0.97	2.91	1.46	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	15.44	4.16	2.97	0.59	0.00	1.19	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	25.99	5.65	3.77	1.13	1.51	0.75	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	25.40	7.26	2.18	2.18	0.73	3.63	1.45	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	20.06	7.52	3.76	0.00	2.51	1.25	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.17	14.00	4.45	1.81	0.82	0.99	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	28.66	12.28	4.09	1.36	0.00	2.73	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	25.48	8.60	3.47	1.81	0.90	1.36	0.00	1.06
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.29	6.97	5.36	1.61	0.00	1.61	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	18.70	7.18	2.65	1.70	0.38	0.94	0.38	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	20.58	5.35	2.94	1.07	0.27	2.14	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	25.36	5.85	0.98	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.91	6.80	3.98	1.16	0.33	0.83	0.33	0.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	25.22	2.40	3.60	0.00	0.00	1.20	0.00	3.60
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	14.16	7.08	3.54	0.00	0.00	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.93	8.58	3.09	0.51	0.17	1.03	0.51	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	0.00	0.00	0.00	0.00	0.00	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	19.90	7.28	5.34	1.46	0.00	0.97	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	22.39	8.73	1.52	0.38	0.76	1.90	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	6.06	3.63	1.21	0.00	0.00	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	17.10	2.85	2.28	2.28	0.00	2.28	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	20.09	7.91	4.06	1.50	0.00	0.86	0.21	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	15.74	6.97	2.58	0.77	0.00	0.52	0.00	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	21.11	7.51	2.82	0.47	0.94	0.47	0.47	1.41
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	26.37	6.11	1.93	0.96	1.29	1.61	0.96	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	15.70	3.57	2.14	1.43	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	21.64	8.77	1.17	2.34	0.58	1.75	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	19.87	5.12	2.41	0.90	0.30	0.60	0.60	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	15.44	9.50	5.94	2.38	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.29	9.66	7.63	0.00	0.00	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	23.18	7.64	3.31	2.04	0.00	0.51	0.76	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	19.06	8.26	2.54	1.91	0.00	0.00	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	16.40	6.47	5.18	0.86	0.86	2.16	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	21.17	7.41	4.02	1.91	0.00	0.85	0.64	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	13.34	4.93	2.61	1.74	0.87	1.74	0.29	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	24.56	3.78	3.78	0.94	1.89	1.89	0.94	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	20.68	7.12	4.41	1.19	1.02	1.36	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	16.21	4.63	2.32	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	33.80	2.11	6.34	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	18.01	7.72	5.15	3.00	0.43	1.07	0.64	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	19.85	7.22	2.41	0.60	0.00	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	18.95	7.29	3.64	2.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	22.76	5.29	1.84	1.61	0.46	0.92	0.23	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	0.00	2.55	2.55	0.00	10.20	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	26.95	6.61	1.27	2.54	1.02	0.76	0.00	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	23.12	9.91	2.89	1.65	0.83	0.83	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	23.56	8.26	5.81	1.53	0.61	0.61	0.92	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	27.25	7.17	5.26	1.43	1.43	1.43	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	23.95	7.76	4.43	0.67	1.11	0.89	0.67	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	18.31	3.05	7.63	3.05	0.00	1.53	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	22.71	9.42	4.98	1.11	0.00	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	17.48	8.21	2.91	1.32	0.26	0.53	0.53	1.32
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.54	7.63	1.09	1.09	0.00	2.18	0.00	1.09
Astrocyte - cerebellum, donor1	11500-119F6	17.07	9.33	5.65	0.86	0.25	1.11	0.00	0.00
Astrocyte - cerebellum, donor2	11580-120F5	11.47	5.82	5.13	2.05	0.17	0.17	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	6.50	3.99	1.05	1.47	0.00	0.21	0.00	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	70.76	33.81	10.46	4.53	4.18	1.74	2.09	1.39
Astrocyte - cerebral cortex, donor2	11316-117D2	57.59	33.81	11.49	4.69	1.62	1.94	2.26	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	59.66	33.11	10.89	4.47	2.09	2.68	1.34	0.89
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	70.88	69.16	24.08	9.17	4.70	2.41	4.47	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	71.16	76.80	22.68	12.03	3.76	2.13	3.38	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	64.52	72.26	22.19	10.24	5.46	2.16	3.07	1.14
Basophils, donor1	12241-129G9	26.68	22.75	6.02	3.66	1.83	0.26	0.26	0.78
Basophils, donor2	12242-129H1	51.23	109.32	20.93	10.82	7.58	1.08	0.36	0.36
Basophils, donor3	12243-129H2	23.52	49.98	17.35	4.12	5.14	0.59	0.29	1.03
Bronchial Epithelial Cell, donor1	11511-119G8	4.96	4.74	1.29	0.22	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	6.40	1.37	0.91	0.00	0.00	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	14.35	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.32	8.79	1.26	1.88	0.63	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	7.28	1.87	1.46	1.04	0.42	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	10.13	2.99	2.53	1.61	0.00	0.46	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	20.87	9.72	4.50	1.08	0.54	0.36	2.34	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	51.32	62.97	36.69	20.92	10.61	1.24	2.58	1.65
Burkitt's lymphoma cell line:RAJI	10476-106I8	71.73	95.96	40.29	13.74	8.62	2.33	6.75	3.73
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	46.05	63.64	17.91	11.51	8.95	0.32	0.00	2.88
CD133+ stem cells - cord blood derived, pool1	12223-129E9	165.47	155.13	31.03	20.68	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	28.18	92.42	31.56	9.02	11.83	1.13	2.25	2.82
CD14+ Monocytes, donor2	11305-117B9	31.00	92.43	38.79	16.33	7.42	1.67	7.61	3.53
CD14+ Monocytes, donor3	11381-118B4	34.47	78.81	29.86	15.15	7.68	1.76	6.37	5.71
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	61.14	32.83	11.60	2.55	4.81	0.28	0.57	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	48.14	42.84	10.99	2.65	2.65	1.14	0.00	1.52
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	54.24	46.68	9.20	1.97	3.62	0.99	0.66	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	31.51	29.63	15.03	6.22	4.19	0.58	3.61	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	34.40	25.04	15.09	5.73	3.92	0.91	3.32	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	40.27	31.51	16.58	8.29	3.32	1.66	2.13	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	26.78	25.11	10.88	7.20	2.85	1.00	1.67	0.84
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	30.64	14.90	10.76	6.35	2.48	1.38	3.31	0.83
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	27.52	21.57	13.14	7.93	3.22	1.74	1.49	1.49
CD14+ monocytes - treated with BCG, donor1	11860-125A6	27.02	17.43	9.79	4.70	2.15	1.17	2.55	0.98
CD14+ monocytes - treated with BCG, donor2	11870-125B7	25.10	23.86	10.50	7.30	3.20	1.42	1.78	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	39.61	24.16	13.06	4.35	2.18	1.96	1.09	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	21.07	26.92	13.81	5.38	3.51	1.40	1.17	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	28.51	33.79	20.59	8.98	1.58	0.53	1.58	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	25.52	39.94	13.31	9.98	4.44	2.22	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	29.90	26.48	9.22	4.91	1.93	1.19	3.27	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	27.34	23.55	7.98	5.79	2.00	0.60	2.20	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	47.47	25.40	10.41	4.79	1.25	2.91	1.04	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	25.40	21.28	13.04	7.09	4.35	0.46	0.92	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	33.03	14.70	10.63	6.11	1.13	1.58	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	15.71	16.59	11.78	6.11	2.18	2.18	2.62	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	32.28	22.06	12.64	6.46	2.15	0.27	1.08	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	37.16	27.91	15.53	5.41	4.71	1.40	3.84	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	34.93	27.77	20.20	4.63	1.68	1.26	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	27.01	21.86	17.45	9.37	2.76	0.73	4.41	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	28.18	13.39	18.32	9.51	2.82	0.70	1.76	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	34.22	19.74	25.45	12.28	2.19	1.32	2.19	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	24.94	19.18	11.51	4.36	2.62	0.17	3.31	1.57
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	25.27	25.27	13.75	5.58	2.60	0.74	10.78	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	43.33	28.45	15.52	5.60	2.59	1.29	0.43	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	21.29	23.34	16.38	7.78	1.64	1.23	3.69	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	35.23	29.67	18.08	11.82	2.55	2.09	0.70	0.46
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	43.61	28.77	20.88	11.14	3.48	1.62	1.86	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	37.27	32.69	13.95	4.14	2.40	1.09	0.22	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	31.88	29.80	15.94	3.70	3.70	0.69	0.00	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	30.54	29.89	10.61	4.55	1.73	0.87	0.43	1.52
CD14+CD16- Monocytes, donor1	11788-124B6	50.77	49.05	25.07	7.94	6.70	1.87	0.62	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	44.88	36.85	24.62	5.41	4.02	1.75	0.35	1.75
CD14+CD16- Monocytes, donor3	11910-125G2	71.35	54.40	29.43	6.02	2.90	2.90	2.01	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	38.28	28.58	17.61	4.34	2.81	0.51	0.26	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	38.86	30.08	23.49	5.49	3.73	0.88	0.00	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	36.21	33.27	18.53	5.90	4.00	2.32	0.21	1.47
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	40.65	63.00	22.36	4.06	6.10	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	51.53	82.71	10.17	9.49	6.78	0.00	0.68	2.71
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	53.85	82.85	9.32	10.36	6.21	2.07	2.07	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	59.17	101.28	18.12	14.39	7.46	0.53	1.60	3.73
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	61.11	92.20	12.87	8.04	6.97	1.07	0.00	3.22
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	52.65	70.90	16.85	7.72	9.83	0.70	0.00	4.91
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	49.41	89.42	16.47	8.63	7.84	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	61.96	80.42	7.91	10.55	2.64	1.32	1.32	1.32
CD19+ B Cells, donor1	11544-120B5	53.42	141.37	33.70	22.19	16.44	2.47	4.93	7.40
CD19+ B Cells, donor2	11624-122B4	71.82	126.95	21.76	13.78	7.98	2.18	6.53	7.25
CD19+ B Cells, donor3	11705-123B4	47.96	127.72	19.69	18.17	14.64	0.00	4.04	7.07
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	120.41	44.04	21.01	14.95	3.64	4.04	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	81.50	32.76	16.38	13.18	4.39	1.60	0.40	2.40
CD34+ Progenitors, donor1	11545-120B6	67.27	79.32	26.11	10.04	3.01	1.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	64.05	74.16	37.08	11.24	6.74	1.12	0.00	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	51.10	72.90	22.17	10.15	7.89	0.38	0.38	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	56.15	64.71	17.59	13.98	6.54	1.58	0.23	1.35
CD4+ T Cells, donor1	11225-116C1	101.05	247.80	42.49	27.85	25.35	1.43	5.71	6.78
CD4+ T Cells, donor2	11306-117C1	60.62	188.61	34.29	22.66	19.60	1.22	11.02	9.80
CD4+ T Cells, donor3	11382-118B5	48.80	150.67	25.92	21.96	12.50	1.22	13.42	8.23
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	74.27	59.73	29.35	6.89	4.85	1.02	1.28	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	63.56	52.78	21.79	8.09	4.72	1.80	1.12	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	67.84	50.02	26.73	10.35	8.34	0.29	0.29	0.86
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	79.65	147.92	51.68	19.91	18.02	1.42	0.95	4.74
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	81.47	159.43	42.84	26.69	19.67	0.70	0.70	4.21
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	62.63	141.74	36.26	16.48	19.78	0.00	3.30	16.48
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	63.59	57.95	16.04	6.79	4.77	1.45	0.87	0.58
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	40.84	45.92	14.57	5.93	3.22	0.68	2.03	3.22
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	44.33	42.40	15.15	6.93	4.84	1.61	1.93	2.26
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	58.28	83.83	21.07	8.52	9.86	2.24	1.79	2.24
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	66.03	86.65	25.85	10.83	9.08	1.75	0.35	2.45
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	80.08	109.56	18.48	11.88	7.04	0.44	2.20	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	63.25	53.13	24.88	8.01	6.32	1.69	2.53	2.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	48.83	49.03	19.53	6.86	5.19	0.21	3.32	3.95
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	44.77	37.09	23.72	4.68	5.35	0.33	1.34	3.01
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	77.23	199.06	42.69	23.39	21.21	1.36	2.45	4.35
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	122.73	197.23	57.35	28.94	26.80	2.14	1.07	3.22
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	77.11	154.22	53.80	21.52	8.97	0.00	3.59	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	76.77	61.75	16.69	6.49	4.64	2.23	0.56	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	61.95	50.26	14.30	3.03	3.68	1.95	1.08	1.95
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	56.95	44.76	18.70	5.04	3.99	0.63	0.63	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	67.25	116.29	29.83	17.19	11.12	1.52	0.51	4.04
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	66.72	102.25	26.43	13.43	13.00	0.87	0.43	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	95.44	139.90	25.71	14.82	10.02	0.87	3.49	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	78.68	126.69	23.75	11.38	18.81	1.98	0.49	7.42
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	76.62	84.93	18.46	12.00	11.08	1.85	0.00	4.62
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	69.79	86.54	26.52	12.56	6.98	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	101.36	86.12	34.89	11.91	8.03	1.11	0.00	1.94
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	101.84	87.36	35.83	12.51	8.10	0.74	0.25	1.72
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	78.54	146.30	15.40	7.70	7.70	4.62	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	81.29	131.43	23.28	10.03	12.89	1.07	0.00	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	76.17	127.42	30.47	8.31	12.46	2.77	0.00	9.69
CD8+ T Cells, donor1	11226-116C2	69.74	200.37	35.36	20.95	19.97	2.29	4.26	5.24
CD8+ T Cells, donor2	11307-117C2	48.43	164.44	28.91	19.52	10.51	1.13	12.76	7.51
CD8+ T Cells, donor3	11383-118B6	66.66	198.20	31.31	23.99	18.43	1.77	15.40	7.57
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	34.87	16.97	4.82	3.44	1.84	0.69	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	30.67	14.14	4.55	3.12	1.20	1.68	0.48	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.74	15.87	6.57	2.74	2.74	1.09	0.55	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	39.03	15.61	6.90	2.70	2.40	0.60	0.60	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	29.76	18.24	2.88	2.40	1.20	0.96	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	30.47	18.19	4.78	1.59	1.82	0.91	0.91	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	35.20	19.12	5.87	2.61	1.96	0.00	0.87	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	36.59	18.16	5.00	2.63	1.32	0.79	0.26	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	35.41	14.54	6.80	1.64	2.11	0.70	0.94	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	35.32	19.92	3.32	3.02	2.42	0.30	1.21	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	31.66	16.56	3.49	5.23	0.87	1.16	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	35.17	21.85	5.06	3.46	3.46	1.87	0.53	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	34.14	25.83	6.57	3.50	1.75	2.19	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.60	14.57	6.83	0.91	1.37	0.91	0.91	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	48.48	18.65	3.73	2.98	2.24	0.00	0.00	2.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	33.13	12.97	5.04	3.60	3.60	1.44	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	33.66	16.40	7.77	2.59	0.58	0.29	0.86	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	27.81	15.32	5.19	2.36	0.71	0.47	0.00	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	41.20	23.45	4.75	4.44	1.27	0.63	0.63	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	41.83	24.91	8.61	4.00	0.62	2.46	0.31	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	37.51	18.91	4.17	2.56	1.28	0.64	1.28	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	32.89	19.12	6.12	3.06	1.53	1.53	0.38	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.01	15.37	5.52	4.34	1.18	2.36	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	31.01	18.91	3.03	3.78	0.00	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	50.59	33.72	9.64	12.04	7.23	3.21	0.00	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	65.05	41.27	12.59	11.89	2.10	3.50	1.40	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	58.10	43.08	15.03	3.01	0.00	2.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	31.07	27.42	1.83	1.83	1.83	3.66	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	20.26	12.35	3.46	0.99	0.99	0.99	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	26.31	9.05	3.37	0.84	0.53	0.74	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	33.63	12.83	9.01	2.08	0.35	1.39	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	17.77	4.98	3.20	0.00	0.71	1.07	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	29.24	18.66	6.60	2.39	1.48	0.91	1.14	0.91
Chondrocyte - re diff, donor2	11339-117F7	43.87	24.17	5.37	3.58	0.00	3.58	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	23.86	23.46	9.30	4.45	2.02	0.40	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	64.26	39.82	14.69	4.13	2.52	3.44	0.57	1.26
Ciliary Epithelial Cells, donor2	11323-117D9	37.62	26.29	9.62	4.92	3.85	2.78	2.35	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	42.92	30.53	11.06	4.69	2.21	2.39	1.86	0.80
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	41.72	44.75	18.62	10.00	8.25	3.39	0.28	1.19
Corneal Epithelial Cells, donor1	11526-119I5	3.95	0.88	1.54	0.22	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	4.55	5.69	3.41	1.14	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	6.65	4.35	2.05	0.00	0.51	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	36.82	18.49	9.91	1.65	0.33	0.66	0.17	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	37.85	14.82	9.15	3.15	0.95	0.00	0.63	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	34.51	20.70	3.45	0.00	3.45	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	26.03	16.74	6.37	1.40	1.30	0.54	1.08	0.54
Dendritic Cells - plasmacytoid, donor1	11228-116C4	70.72	95.32	15.37	8.88	11.62	0.68	1.02	7.86
Dendritic Cells - plasmacytoid, donor2	11309-117C4	71.16	103.15	15.02	7.83	9.79	0.65	0.00	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	100.66	66.30	20.33	6.29	9.68	3.39	0.00	0.97
Endothelial Cells - Aortic, donor0	11207-116A1	24.68	8.51	1.83	1.17	1.33	0.83	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	14.67	6.45	1.17	1.17	0.59	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	20.64	5.66	3.39	1.13	0.57	0.85	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	12.19	7.47	6.29	2.36	0.39	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	13.67	8.73	2.91	1.16	0.29	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	21.88	6.12	2.12	0.71	0.71	1.41	0.00	0.00
Endothelial Cells - Artery, donor3	11413-118E9	20.86	6.14	1.40	0.88	1.23	0.70	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.22	17.73	9.09	2.22	2.88	0.66	0.00	1.11
Endothelial Cells - Lymphatic, donor2	11317-117D3	49.90	18.86	12.47	3.65	3.04	1.52	0.00	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	53.84	25.09	7.89	3.38	1.41	0.85	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	15.15	3.57	2.67	0.89	0.00	0.59	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	13.02	5.21	2.60	0.52	0.52	1.04	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	12.05	5.67	3.54	0.71	0.57	0.43	0.57	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	40.41	8.80	5.60	2.40	0.80	2.80	0.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	10.48	5.24	3.14	0.52	1.05	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	69.21	40.38	14.91	6.59	3.85	2.24	0.62	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	29.55	21.07	12.60	6.52	1.96	0.87	0.00	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	42.87	23.94	10.38	6.11	2.20	2.08	0.24	0.24
Endothelial Cells - Vein, donor1	11267-116G7	15.93	6.83	5.69	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	20.96	6.29	3.49	2.10	1.40	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	23.71	9.89	4.71	1.73	1.57	0.63	0.31	0.31
Eosinophils, donor1	12244-129H3	30.49	60.99	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	21.45	92.41	67.66	14.85	4.95	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	24.97	60.64	42.80	14.27	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.62	3.91	2.20	0.98	0.00	0.24	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	33.25	20.53	9.85	4.11	0.41	0.82	1.64	2.05
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	11.61	2.96	1.31	0.44	0.11	1.42	0.33	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	19.83	7.91	1.84	0.98	0.54	1.30	0.22	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	41.72	19.65	6.79	2.67	1.70	3.03	0.61	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	109.86	89.25	48.04	14.19	8.05	4.78	2.18	1.36
Fibroblast - Aortic Adventitial, donor2	11326-117E3	23.73	13.71	5.17	2.43	0.32	1.05	1.69	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	65.08	35.31	32.67	10.01	3.16	1.32	1.05	2.37
Fibroblast - Aortic Adventitial, donor3	11401-118D6	32.89	22.92	8.64	2.66	1.66	2.33	3.65	0.66
Fibroblast - Cardiac, donor1	11268-116G8	19.96	16.33	4.54	2.27	1.36	2.27	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	15.16	10.61	1.52	1.52	0.00	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.25	9.46	3.00	0.63	0.47	0.79	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	70.02	45.47	15.16	6.37	1.82	2.42	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	36.17	17.26	8.88	2.54	2.03	1.14	0.25	0.38
Fibroblast - Cardiac, donor6	11460-119B2	39.11	13.64	7.43	2.88	1.21	1.36	0.15	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.86	15.54	7.77	2.01	0.54	0.94	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	20.71	14.24	4.75	1.73	0.86	0.43	0.86	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	1.46	4.39	0.00	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	14.07	12.22	3.92	1.61	1.85	1.38	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	37.14	25.61	4.58	1.19	1.36	0.85	0.68	0.34
Fibroblast - Dermal, donor1	11269-116G9	29.58	9.39	5.17	1.41	0.47	2.35	1.41	0.00
Fibroblast - Dermal, donor2	11346-117G5	16.04	7.08	3.30	1.42	0.00	1.42	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	28.29	18.01	3.99	0.97	0.85	1.45	2.42	0.12
Fibroblast - Dermal, donor4	11450-119A1	49.63	15.49	10.85	2.83	1.36	2.15	0.34	0.45
Fibroblast - Dermal, donor5	11454-119A5	54.43	13.61	9.25	4.01	1.57	2.97	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	52.30	16.40	10.72	3.41	1.30	3.90	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	52.68	18.53	8.95	2.92	2.29	2.71	0.21	0.62
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	44.54	26.20	11.00	6.03	2.10	2.62	1.05	0.26
Fibroblast - Gingival, donor2	11318-117D4	45.47	27.81	6.33	3.03	1.84	1.84	2.37	0.66
Fibroblast - Gingival, donor3	11394-118C8	52.50	28.91	7.73	2.61	2.13	2.80	0.10	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	46.75	14.54	9.35	2.08	2.08	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	25.73	13.92	6.17	2.11	1.41	1.94	1.94	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	41.16	26.19	9.04	2.96	2.18	3.27	1.71	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	53.41	18.80	5.95	1.89	0.41	4.19	0.68	0.95
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	39.88	8.82	9.53	1.41	0.71	1.41	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	42.56	18.28	8.04	2.63	0.88	3.22	0.88	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	52.09	17.45	7.36	3.41	0.95	3.55	1.91	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	44.54	15.36	5.70	2.96	1.21	2.19	0.77	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	61.63	26.12	15.11	4.99	2.49	2.05	0.73	1.03
Fibroblast - Lung, donor1	11270-116H1	9.52	1.36	2.72	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	53.72	10.45	1.49	0.00	1.49	2.98	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	27.65	10.34	2.95	0.63	0.63	1.48	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	12.50	4.17	0.83	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	5.59	1.40	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	2.80	1.40	0.84	0.28	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	24.36	4.87	4.47	1.62	0.81	0.81	0.41	0.00
Fibroblast - Mammary, donor2	11620-122A9	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	5.96	0.00	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	63.04	26.19	9.89	2.91	2.13	1.94	0.39	1.16
Fibroblast - Periodontal Ligament, donor2	11319-117D5	63.25	29.88	13.04	5.61	3.79	4.10	0.61	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	87.82	37.94	10.10	4.90	1.53	7.04	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	33.96	12.98	5.34	3.05	0.76	3.43	0.38	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	29.70	12.96	5.94	2.43	0.54	1.89	0.00	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	30.15	13.68	6.49	1.62	0.93	1.39	0.81	0.70
Fibroblast - Pulmonary Artery, donor1	11250-116E8	34.71	13.26	3.09	1.99	1.22	1.55	0.22	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	15.44	8.33	1.83	0.41	0.41	0.41	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	8.69	3.34	0.00	0.67	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	25.70	11.86	3.95	1.98	0.79	0.00	0.40	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	102.60	37.51	32.55	9.72	1.98	3.77	1.79	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	36.41	23.09	9.77	2.31	1.95	1.24	0.89	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.95	27.20	10.05	3.35	1.18	2.17	1.38	0.59
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	64.38	28.58	20.46	8.12	2.71	1.81	0.90	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	62.07	21.27	12.74	3.02	1.19	1.73	0.11	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	90.60	47.07	36.70	7.59	4.05	2.53	0.25	2.78
Fibroblast - skin normal, donor1	11553-120C5	36.92	17.88	8.53	2.63	0.66	2.13	1.31	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	112.69	69.38	40.50	8.02	6.42	7.62	3.01	2.01
Fibroblast - skin normal, donor2	11561-120D4	51.14	12.36	10.05	1.31	0.60	1.51	0.10	0.70
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	104.27	45.34	31.43	6.95	2.72	2.42	2.12	2.72
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	50.62	28.66	10.44	3.89	2.65	1.57	0.50	0.50
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	70.43	28.38	14.02	3.76	1.88	2.05	0.17	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	87.03	27.92	31.53	6.57	4.27	1.97	0.33	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	48.89	15.34	9.69	2.77	0.96	2.13	0.00	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	36.94	12.65	5.23	2.36	0.84	1.52	1.35	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	16.31	5.33	1.88	0.47	0.16	1.25	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	221.60	44.32	44.32	0.00	0.00	0.00	44.32	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	29.63	35.73	39.22	6.10	3.49	0.87	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	36.58	7.45	6.07	1.56	1.21	2.43	0.00	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	42.42	14.31	8.33	1.82	0.78	2.86	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	44.97	17.89	10.48	1.28	1.53	2.04	0.51	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	41.34	22.97	13.01	6.89	2.30	0.00	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	40.84	26.16	14.68	12.76	3.83	0.64	0.64	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	59.62	22.54	49.07	18.83	6.56	2.57	5.13	3.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	96.52	36.12	52.95	9.65	3.31	3.58	5.79	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	67.36	28.54	37.22	11.87	6.16	0.68	4.34	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	46.76	22.39	51.12	13.87	6.74	2.58	6.14	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	81.94	29.87	45.47	7.67	3.97	2.64	3.70	2.11
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	78.60	26.42	52.18	16.31	2.94	1.63	2.61	2.94
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	53.07	25.21	38.03	13.71	3.10	1.33	10.17	4.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	37.59	25.58	30.95	11.59	5.65	1.70	2.69	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.54	24.26	19.09	10.47	4.43	1.11	2.59	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	28.47	22.56	19.34	9.13	2.95	1.34	3.22	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	39.89	19.45	11.89	6.57	1.73	1.36	3.10	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	39.59	15.78	15.64	6.51	2.08	2.35	0.97	0.42
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	35.58	17.08	13.01	4.88	2.85	1.63	1.63	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	35.14	16.43	11.18	4.56	1.83	0.91	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	40.73	21.30	12.58	5.23	2.74	1.25	1.62	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	40.66	17.05	20.55	4.81	2.19	0.22	1.75	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	42.25	20.39	7.09	5.02	1.48	1.48	0.30	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	40.69	28.29	14.62	7.31	2.70	0.64	2.38	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	38.20	15.86	9.38	7.15	1.34	1.34	1.34	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	46.38	20.77	7.26	4.44	1.81	1.01	1.01	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	46.65	24.77	7.29	4.41	3.22	1.19	3.22	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	54.80	26.07	11.62	5.85	2.57	1.60	0.44	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	63.16	23.00	7.80	5.41	2.50	1.35	0.83	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	52.94	21.01	8.20	2.22	2.05	0.68	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	45.15	26.34	11.51	4.87	2.88	1.22	1.55	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	55.91	30.87	10.65	6.82	3.33	1.58	0.42	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	48.19	25.93	10.41	5.51	2.04	0.61	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	43.74	19.81	5.78	4.54	1.86	0.62	1.65	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	46.92	22.14	11.18	5.07	3.46	0.81	1.84	1.15
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	38.36	25.68	11.17	4.84	2.50	1.00	2.33	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	34.39	16.31	4.63	3.09	2.65	1.10	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	42.80	23.86	9.10	2.83	2.58	1.84	1.60	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	36.80	24.31	9.40	3.73	3.08	1.78	0.65	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	34.64	20.85	6.09	2.89	4.81	0.96	1.28	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	35.82	19.99	7.20	3.70	1.99	0.57	1.23	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	35.91	18.82	5.22	3.16	0.79	1.74	1.11	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	27.98	21.29	4.56	3.04	0.61	0.61	1.82	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	43.17	18.40	7.74	3.97	1.88	0.84	1.78	1.25
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	33.37	19.10	6.15	2.20	1.98	0.22	0.22	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	35.35	19.64	7.01	1.96	1.12	0.28	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	34.91	21.85	5.56	4.07	2.22	1.20	2.13	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.47	16.31	2.67	2.94	0.80	2.41	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	30.45	18.05	4.13	2.45	1.99	1.07	0.92	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	34.46	16.19	4.15	1.81	1.04	2.46	0.91	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	31.44	16.81	4.34	2.44	1.63	0.54	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	40.00	18.80	4.42	3.50	1.66	0.74	1.29	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	37.06	17.55	5.26	1.97	1.54	0.44	1.54	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	53.55	25.79	6.94	6.94	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	32.45	19.39	3.30	3.17	1.58	0.92	0.53	0.92
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	35.31	14.12	4.44	2.42	1.21	1.41	1.21	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	69.64	23.64	9.15	3.81	2.80	1.52	0.51	0.76
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	57.93	17.72	47.97	16.32	4.98	1.00	0.60	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	40.83	26.96	33.59	16.33	5.85	1.23	3.08	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	48.08	37.64	41.53	20.25	7.16	2.05	2.86	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	33.80	22.22	16.27	8.76	2.19	0.31	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	38.43	21.76	14.98	9.04	2.26	1.41	1.13	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	51.65	32.28	39.20	10.61	3.23	1.84	1.38	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	44.55	12.37	29.70	7.42	0.00	0.00	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	47.96	34.43	23.98	11.99	1.16	0.77	4.64	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	30.48	28.88	25.67	14.44	1.60	3.21	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	39.99	38.25	13.91	5.22	1.74	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	39.38	25.39	18.88	9.44	2.60	0.98	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	49.00	28.83	31.30	13.18	2.06	0.82	3.71	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	59.98	43.32	10.00	16.66	6.66	0.00	16.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	46.42	31.60	17.06	7.55	2.52	2.52	1.96	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	50.66	25.82	18.63	7.84	3.27	1.31	2.29	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.14	26.00	22.65	7.55	3.36	1.68	7.55	5.87
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	62.02	34.03	16.54	8.91	2.86	2.23	2.23	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	43.48	21.40	11.55	5.77	1.36	1.70	2.04	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	50.12	27.15	25.06	2.09	2.09	2.09	6.26	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	55.55	27.49	12.03	6.87	2.86	1.72	4.01	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	35.22	14.21	9.77	3.26	1.78	0.89	1.78	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	52.52	23.72	20.33	6.78	1.69	0.00	1.69	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	53.02	33.55	19.47	9.11	2.49	1.66	2.49	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	43.49	29.46	11.97	9.44	3.22	2.07	1.61	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	31.61	10.54	0.00	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	40.75	25.76	9.23	5.77	1.54	2.31	3.84	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	55.74	25.75	11.73	6.85	3.26	1.30	2.61	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	46.82	14.71	18.73	3.34	2.68	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	58.56	23.12	18.11	4.62	2.31	0.77	0.77	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	46.56	41.42	16.77	14.04	4.11	1.71	5.14	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	32.30	27.33	4.97	7.45	0.00	2.48	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	50.49	25.01	14.63	5.19	2.36	0.94	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	41.04	21.73	11.47	6.03	1.21	1.21	1.81	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	52.39	25.94	22.38	8.65	5.09	1.53	1.53	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	52.25	30.31	17.55	3.59	3.99	1.20	2.79	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	61.18	20.72	21.21	11.35	1.97	1.48	2.47	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	56.66	44.86	21.25	8.26	4.72	2.36	2.36	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	51.34	21.59	13.42	2.92	4.67	1.17	1.75	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	54.86	19.31	19.31	5.27	3.95	0.00	1.76	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	48.32	27.13	13.56	4.24	1.70	1.70	5.93	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.80	17.31	14.92	4.78	3.58	0.60	1.19	2.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	43.19	21.84	8.25	4.37	1.94	0.49	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	5.71	1.14	0.00	0.00	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	24.12	12.06	3.33	1.66	0.00	1.66	0.83	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	13.49	1.12	3.37	3.37	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	26.01	13.96	6.98	1.27	0.95	1.59	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	17.96	5.01	4.18	0.42	0.84	2.09	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	22.63	20.54	4.29	3.83	2.20	1.74	1.39	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	30.38	21.94	8.61	4.73	2.19	2.19	0.68	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	21.16	16.61	7.74	2.73	2.05	1.59	1.37	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	21.75	20.33	4.81	4.81	1.64	1.20	1.09	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	21.71	20.42	5.37	3.01	1.07	1.29	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	22.17	20.88	6.46	4.09	2.15	1.08	0.65	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	23.54	17.31	5.85	3.74	1.87	0.75	0.50	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	25.39	19.21	6.35	3.43	1.89	2.74	0.86	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	16.34	16.34	4.49	2.56	0.32	1.28	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	14.55	2.80	5.04	2.80	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	5.63	2.16	1.30	0.43	0.87	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	7.93	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	11.64	8.47	3.17	1.06	1.06	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	7.99	0.73	1.45	0.00	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	18.53	11.01	1.92	1.22	0.87	1.22	0.70	0.00
Hepatocyte, donor1	11523-119I2	23.00	43.58	9.68	7.26	3.63	0.00	1.21	3.63
Hepatocyte, donor2	11603-120I1	33.40	45.25	10.77	8.62	3.23	0.00	2.15	2.15
Hepatocyte, donor3	11684-122I1	22.09	47.24	21.47	12.27	3.68	1.23	6.75	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	48.30	127.27	15.66	11.75	7.83	3.26	2.61	4.57
Intestinal epithelial cells (polarized), donor1	11246-116E4	29.71	23.60	8.74	6.47	3.32	0.35	0.52	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.79	16.33	3.43	1.92	1.10	1.65	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	12.74	28.66	15.92	15.92	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	6.68	6.68	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	24.92	24.92	15.23	13.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	12.51	10.01	2.50	5.01	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	11.87	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	20.50	30.75	10.25	5.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	0.00	4.57	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	16.24	22.74	21.12	3.25	1.62	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	21.67	11.67	6.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	14.52	3.63	7.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	19.85	34.41	19.85	10.59	1.32	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	16.63	23.28	11.09	4.43	2.22	0.00	0.00	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	31.43	31.43	5.24	15.71	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	25.82	29.60	13.86	8.19	1.89	1.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	26.29	21.65	6.19	9.28	0.00	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	29.27	43.90	0.00	0.00	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	25.20	34.89	23.90	10.34	3.23	0.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	32.20	46.69	32.20	17.71	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	71.69	23.90	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	33.41	39.93	23.63	12.22	2.44	2.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	25.19	26.45	12.59	3.78	2.52	0.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	14.37	14.37	14.37	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	25.72	45.81	19.29	12.86	0.00	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	16.62	22.16	11.08	11.08	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	75.40	105.57	30.16	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	20.77	29.74	13.22	6.14	1.89	0.47	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	15.42	39.00	14.51	5.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	44.23	88.45	29.48	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	22.60	41.97	29.06	20.45	2.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	21.60	39.38	33.03	15.25	2.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	115.01	49.29	16.43	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	18.49	48.46	21.68	13.39	2.55	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	29.16	58.33	21.87	21.87	1.82	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61	47.41	31.61	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	28.56	54.98	24.99	18.57	2.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	13.27	76.32	26.55	26.55	0.00	6.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	125.09	41.70	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	15.12	33.64	20.06	8.03	0.62	0.62	0.62	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	21.07	38.63	24.58	12.29	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	28.29	18.86	9.43	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	22.25	28.51	23.64	11.13	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	22.13	0.00	11.07	6.64	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	25.94	22.69	6.48	9.73	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	18.31	13.95	7.85	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	15.75	27.00	15.75	9.00	2.25	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	17.42	10.45	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	11.73	14.93	14.93	6.40	5.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	18.01	23.55	9.70	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	22.80	37.04	31.35	11.40	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	17.49	16.57	18.41	16.57	1.84	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	12.10	6.05	9.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	18.63	31.04	18.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	13.75	9.52	5.29	6.34	3.17	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	24.32	6.77	3.35	0.82	0.49	2.77	0.33	0.16
Keratinocyte - epidermal, donor2	11349-117G8	4.69	3.51	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	33.79	14.96	3.69	0.85	1.14	1.51	1.89	0.28
Keratinocyte - oral, donor1	11251-116E9	61.98	22.02	9.99	2.16	1.25	2.16	1.02	0.23
Keratocytes, donor1	11527-119I6	23.38	8.94	2.06	1.38	1.03	1.72	0.00	0.00
Keratocytes, donor2	11607-120I5	10.55	3.52	2.34	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	29.64	15.41	3.16	2.57	1.78	0.99	1.38	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	26.37	6.59	15.39	6.59	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	25.89	14.02	3.24	2.16	0.00	2.16	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	43.60	22.03	5.54	1.85	2.08	0.69	1.38	0.58
Lens Epithelial Cells, donor3	11690-122I7	31.79	14.63	5.25	1.31	0.71	1.21	0.20	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	20.28	9.25	2.85	1.42	0.71	0.71	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.63	5.86	1.40	0.84	0.56	0.56	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	24.71	10.86	5.04	3.78	2.20	0.63	1.89	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.59	3.76	1.08	1.08	0.00	1.61	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	9.77	3.78	0.95	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	9.27	4.10	1.19	0.54	0.32	0.43	0.32	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	24.62	7.80	4.92	0.82	0.82	0.41	0.82	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	5.81	4.05	1.26	0.76	0.51	0.51	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	11.82	5.91	2.53	1.27	0.56	0.56	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	21.36	5.14	2.37	0.79	0.40	0.40	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	19.97	7.56	1.74	1.16	0.39	0.00	0.78	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	5.55	3.15	0.74	0.56	0.00	0.37	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.51	8.01	4.53	0.35	1.39	0.00	1.05	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.27	5.72	3.10	0.95	0.48	0.95	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	9.48	3.85	1.65	1.10	0.41	0.00	0.96	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	24.33	6.47	1.54	2.46	0.92	0.31	2.16	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	9.98	2.81	0.62	0.31	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	7.32	4.03	2.56	0.18	0.73	0.37	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	23.04	7.57	2.96	0.33	0.66	0.66	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	14.06	2.93	1.17	1.17	0.00	0.29	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	5.23	4.98	0.75	0.00	0.75	0.25	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	25.70	10.18	2.91	1.45	0.00	0.00	0.97	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	18.04	6.73	1.62	0.81	1.35	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	11.81	5.45	1.51	1.06	0.76	0.45	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	19.18	7.78	1.04	1.04	1.04	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	25.76	13.82	4.61	1.88	0.84	1.26	0.42	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	9.47	3.91	1.20	0.60	0.30	0.00	0.60	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.69	8.25	2.06	1.38	0.00	1.38	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	18.63	5.83	2.63	0.56	0.38	1.69	0.56	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	9.12	3.07	1.38	0.21	0.32	0.11	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	21.81	7.27	2.42	0.97	0.00	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	10.25	7.61	1.98	0.66	0.66	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	6.81	4.58	0.99	0.62	0.50	0.50	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.62	11.11	7.77	1.85	1.11	0.00	0.74	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	20.01	9.14	1.48	1.73	0.49	0.00	1.48	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	6.74	3.85	0.96	0.82	0.41	0.27	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.98	9.65	3.86	1.93	0.00	0.32	0.32	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	28.00	10.04	4.87	3.04	0.91	0.00	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	22.53	11.06	3.64	1.40	1.54	0.70	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	22.40	9.60	2.49	1.42	1.07	1.42	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	10.18	6.30	1.94	0.48	0.48	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	5.45	1.40	0.62	0.16	0.16	0.62	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	15.40	3.94	2.86	2.86	0.72	0.36	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	14.37	4.57	1.63	0.98	0.65	0.33	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	4.94	3.53	1.65	0.71	0.47	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	17.94	6.19	2.97	0.87	0.62	0.87	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	12.55	3.84	0.51	1.02	0.00	0.26	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	7.76	3.28	2.69	0.30	0.00	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	9.06	2.27	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	3.07	9.97	4.60	3.07	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.20	11.13	5.20	0.74	2.23	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5.50	6.77	3.39	1.69	0.42	1.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	4.22	5.63	5.63	2.11	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	4.67	2.80	1.87	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	2.58	4.64	0.52	0.52	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	2.38	5.95	4.76	0.00	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.43	7.69	3.62	1.58	0.23	0.45	0.00	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	7.27	11.92	4.65	1.45	0.58	0.87	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	8.55	13.96	4.50	0.45	0.45	0.90	1.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	6.77	8.40	4.06	0.41	1.08	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	4.62	7.19	3.59	0.51	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	5.65	13.41	5.65	1.76	1.41	0.35	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	4.00	9.99	2.67	1.33	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	4.58	11.21	2.55	2.55	1.02	0.51	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	9.07	14.67	7.20	2.13	2.93	0.53	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	9.26	12.66	4.35	1.32	0.94	0.00	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	4.91	9.82	6.75	1.84	0.00	0.61	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	9.79	3.26	0.82	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	9.16	12.91	5.21	2.71	0.21	0.21	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	10.09	10.65	5.32	1.68	0.56	0.00	0.56	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	8.24	10.30	5.15	0.00	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	10.45	11.61	6.68	2.03	1.45	0.87	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	9.27	10.16	5.08	1.20	0.60	0.60	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	7.75	16.60	5.53	2.77	0.55	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	7.07	7.07	4.24	1.06	1.06	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	8.11	10.33	3.32	1.11	0.00	0.74	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	4.61	2.30	3.45	0.00	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.06	11.51	2.30	1.15	0.77	0.00	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	3.40	7.36	2.83	1.13	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	9.85	1.64	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	5.87	7.23	3.16	2.71	0.90	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	7.90	6.46	2.15	1.44	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	7.47	11.95	5.23	1.49	0.75	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	5.95	10.03	4.46	0.37	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	8.61	12.92	5.17	1.29	0.86	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.99	11.99	5.14	0.00	0.86	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	6.00	9.00	3.66	0.33	0.67	0.33	0.00	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.86	7.24	5.43	3.02	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	5.69	11.38	4.27	0.71	0.71	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	4.47	6.53	2.41	2.75	0.00	0.34	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.29	10.20	2.15	0.54	1.07	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5.39	9.43	2.69	0.67	1.35	0.00	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	5.93	8.89	5.19	1.85	1.48	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	4.65	10.47	4.65	1.16	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	6.35	6.35	2.12	0.00	0.00	0.00	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	8.00	6.40	3.20	1.20	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	4.36	5.09	3.63	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.13	9.20	5.37	0.77	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	5.43	6.41	3.45	0.49	0.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	7.53	5.65	2.82	6.59	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	5.53	5.03	4.02	1.01	0.50	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	6.76	7.21	4.06	2.25	2.25	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	12.05	5.16	5.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.23	7.13	4.90	1.78	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	3.91	7.82	3.91	1.17	0.00	0.39	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	8.58	9.24	1.98	3.30	0.66	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	3.63	10.38	4.67	0.52	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	6.13	7.88	7.44	0.00	0.44	0.88	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	5.03	7.83	5.59	1.68	0.00	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	7.51	10.60	7.07	0.88	1.32	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.56	8.87	4.63	1.54	0.77	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	4.05	7.09	2.53	2.53	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	10.09	12.02	3.84	0.96	1.92	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	5.57	7.95	1.99	0.40	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.08	7.29	5.47	2.43	0.61	0.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	4.84	2.77	1.38	0.69	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	7.60	6.84	4.18	1.14	1.52	0.00	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.16	8.26	5.68	1.03	0.00	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	3.63	6.05	2.42	2.42	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	8.24	12.36	4.12	1.90	0.95	0.95	0.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	4.80	5.86	3.73	3.73	0.00	1.07	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6.90	4.60	0.57	0.57	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	5.66	5.66	3.60	1.54	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.07	6.37	4.24	0.71	0.00	1.41	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	9.08	8.51	2.84	2.27	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	3.33	5.82	5.82	1.66	0.00	0.42	0.83	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	5.48	10.96	2.35	2.35	0.78	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	3.34	5.01	3.34	1.67	1.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	5.11	5.11	2.32	1.39	0.46	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	5.35	10.70	1.34	0.67	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	7.48	6.42	4.28	1.07	0.00	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	6.47	6.47	2.83	1.21	0.00	0.00	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	3.67	8.26	0.92	0.00	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	8.89	2.67	3.56	0.00	0.89	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	3.42	10.83	2.28	1.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	6.14	9.97	3.07	0.77	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	9.30	7.11	2.74	1.64	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	4.90	5.79	4.90	0.45	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.84	8.58	2.86	1.56	0.26	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	5.30	7.29	2.65	0.66	1.99	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	4.16	16.63	0.00	2.08	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	33.96	18.01	9.57	1.14	1.14	0.68	0.23	1.37
Macrophage - monocyte derived, donor2	11313-117C8	26.24	12.11	4.77	0.92	1.10	1.84	0.55	0.37
Macrophage - monocyte derived, donor3	11389-118C3	27.13	14.29	7.60	1.18	1.70	0.79	0.39	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	28.14	7.43	3.72	2.12	0.00	3.19	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	50.55	8.71	6.65	1.43	0.48	2.54	0.16	0.32
Mallassez-derived cells, donor3	11930-125I4	47.26	10.01	6.81	0.83	0.56	2.92	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	71.25	25.61	5.48	1.89	0.70	4.48	1.69	0.40
Mammary Epithelial Cell, donor2	11350-117G9	53.28	19.11	4.92	1.74	0.58	6.08	2.90	0.00
Mammary Epithelial Cell, donor3	11422-118F9	11.47	2.74	0.50	0.50	0.00	2.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	156.60	140.33	31.86	10.17	4.75	13.56	1.36	0.00
Mast cell, donor1	11563-120D6	52.66	33.42	17.19	3.03	3.03	1.51	1.30	0.76
Mast cell, donor2	11565-120D8	43.98	65.38	32.99	5.05	5.05	1.19	2.08	0.59
Mast cell, donor3	11566-120D9	53.35	85.55	45.70	12.38	13.73	1.58	1.58	1.58
Mast cell, donor4	11567-120E1	54.78	52.48	25.35	4.79	7.27	1.42	0.00	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	53.45	29.72	13.42	2.99	1.89	1.22	2.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	46.69	40.27	6.42	5.84	2.33	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	50.59	26.27	16.18	3.33	2.87	1.26	0.34	0.34
Mast cell, expanded, donor8	11941-126A6	46.53	39.67	20.59	6.03	3.01	1.34	0.67	1.34
Melanocyte - dark, donor1	11502-119F8	31.64	11.54	5.67	1.79	1.99	1.09	0.10	0.10
Melanocyte - dark, donor2	11582-120F7	21.80	13.15	4.50	0.69	0.69	1.38	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	44.55	25.57	4.42	1.09	1.88	1.09	0.58	0.07
Melanocyte - light, donor1	11274-116H5	10.81	6.35	2.82	0.00	0.24	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	6.82	4.09	1.36	0.00	0.00	0.68	0.00	0.00
Melanocyte - light, donor3	11423-118G1	7.81	2.60	1.73	1.73	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	31.97	20.83	6.87	1.87	1.87	1.87	1.56	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	26.36	18.29	2.42	1.88	2.15	0.81	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	38.04	23.57	5.09	2.41	1.07	0.27	0.80	1.34
Meningeal Cells, donor1	11493-119E8	26.80	9.18	3.97	1.98	0.62	0.62	0.00	0.00
Meningeal Cells, donor2	11573-120E7	24.65	11.00	3.96	1.76	0.44	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	47.60	23.96	3.59	1.14	1.22	3.34	0.49	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	43.63	13.69	5.70	1.71	0.86	2.00	0.29	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	36.73	25.06	10.87	4.53	2.21	1.61	0.10	0.60
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	11.83	6.57	3.94	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	2.62	1.31	1.31	0.00	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.14	20.09	3.59	0.72	1.44	1.44	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	34.73	14.82	8.26	2.33	0.85	1.69	0.64	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	24.63	13.57	5.03	5.53	1.01	1.51	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	10.77	10.33	2.64	1.32	0.88	0.66	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	8.04	2.19	5.11	3.65	1.46	1.46	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	9.62	6.14	3.07	0.82	0.20	0.20	0.00	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	35.32	10.80	6.37	0.83	0.28	0.83	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	3.72	6.32	1.12	0.37	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	40.00	18.16	3.03	2.50	1.71	1.05	1.45	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.31	7.12	3.26	0.59	0.59	0.59	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	2.34	2.34	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	15.37	5.76	4.48	3.20	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	40.41	15.95	4.96	2.13	0.71	1.42	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	32.21	15.64	3.75	1.25	0.63	0.94	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	24.67	16.69	6.53	5.08	0.00	1.45	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	39.78	12.73	6.10	1.86	1.06	3.18	0.80	0.27
Mesothelial Cells, donor2	12156-128G5	17.02	7.51	8.01	2.00	0.50	2.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	27.17	10.98	5.85	1.59	0.79	1.52	1.81	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	24.31	2.70	4.05	0.00	0.00	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	27.58	9.60	6.40	1.97	1.23	1.48	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	31.80	9.13	5.59	0.59	0.88	2.06	0.00	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	10.37	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	27.90	10.23	3.72	0.62	0.93	0.93	1.24	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	22.82	8.30	3.73	1.04	1.24	1.45	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	11.58	4.63	6.95	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	25.53	8.51	5.51	0.50	0.25	1.50	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	31.65	7.45	6.05	0.47	0.47	0.47	1.40	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	19.51	7.32	2.44	0.20	0.81	0.61	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	25.34	11.88	6.73	1.19	1.19	1.58	0.79	1.98
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	8.55	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	8.85	3.54	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.90	5.70	5.32	2.28	0.76	1.90	0.00	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	11.84	6.58	6.58	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.47	7.64	3.82	1.70	1.06	1.06	0.21	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	13.81	9.21	6.45	0.92	0.00	0.92	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	18.78	6.86	5.37	1.19	0.00	1.19	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	1.68	10.06	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	25.09	6.02	4.77	2.26	0.00	1.00	1.76	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.53	5.47	5.47	1.43	0.24	1.19	2.38	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.14	6.08	14.37	3.32	0.55	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	22.10	4.60	6.22	1.84	0.23	1.84	1.15	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	33.23	7.78	5.26	1.68	0.42	1.68	0.84	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	24.66	6.93	5.91	1.02	0.20	1.83	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	23.38	5.15	7.08	1.29	1.07	2.15	0.21	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	27.34	5.78	8.00	1.33	1.11	2.00	0.44	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	23.43	4.16	4.82	2.63	0.22	1.53	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	25.85	5.07	5.07	0.00	0.00	3.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	6.63	4.97	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	24.19	4.89	6.25	1.90	0.27	2.99	0.82	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.41	5.00	5.00	0.59	0.00	3.23	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	23.99	2.18	5.45	1.09	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	22.59	2.88	3.84	0.48	0.48	2.88	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	44.03	3.60	4.00	0.80	0.40	5.20	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	12.34	4.11	2.74	2.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	26.53	1.00	5.01	0.50	0.00	4.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	10.19	0.00	14.27	0.00	0.00	6.12	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	35.47	8.76	8.76	1.75	0.00	7.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	16.55	2.21	1.10	1.10	0.00	1.10	1.10	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	19.21	3.20	6.40	1.92	0.00	1.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	38.18	5.70	4.21	1.24	0.25	4.46	0.25	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	2.09	0.70	0.70	0.00	1.39	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	28.73	6.63	15.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	24.27	5.81	6.50	0.68	0.00	1.71	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	32.82	1.75	4.81	0.00	0.00	2.63	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	19.53	4.26	8.52	1.07	0.36	1.42	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	37.87	5.89	5.33	2.24	0.00	3.09	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	30.76	3.74	7.07	0.00	0.83	2.08	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.40	5.83	9.32	1.75	0.58	1.17	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	30.17	6.33	6.94	1.51	0.00	3.02	0.90	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	42.57	5.01	8.77	1.25	0.42	5.01	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	28.63	8.31	11.08	0.92	0.00	2.77	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	39.27	5.12	6.26	1.71	0.57	2.28	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	20.17	8.01	7.60	0.97	0.28	2.21	0.41	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	29.54	5.44	4.92	1.55	0.26	3.11	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	33.89	4.72	7.29	1.29	0.43	3.00	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	17.79	5.08	10.16	2.54	0.00	0.64	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	25.89	5.07	12.01	2.40	0.27	1.33	0.27	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	34.12	12.27	11.37	2.39	0.30	1.80	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	18.50	7.63	11.02	1.70	0.57	0.99	0.71	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	23.89	6.37	9.87	2.23	0.00	3.50	0.64	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	40.25	5.31	8.85	1.99	0.44	3.54	0.88	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	18.96	6.45	12.13	2.65	0.38	2.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	29.55	6.82	15.06	1.99	0.28	2.27	0.00	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	33.68	8.85	9.09	1.23	0.00	4.18	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	7.17	11.73	4.56	0.65	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	18.52	8.23	10.29	1.18	0.29	0.59	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.68	13.26	10.38	2.59	1.15	2.02	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.49	19.37	11.54	3.30	0.00	1.24	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	17.27	15.48	10.12	2.38	1.19	0.30	0.89	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	15.07	0.00	0.00	0.00	3.77	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	16.04	10.69	0.00	0.00	1.78	0.00	3.56	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	22.67	12.16	3.29	0.66	0.33	0.99	1.31	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	15.78	4.21	1.05	0.00	0.00	0.00	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	29.26	8.30	3.76	0.99	1.58	0.40	0.40	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	28.87	5.59	0.00	0.93	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	24.41	5.63	2.63	0.00	0.75	0.38	1.88	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.38	3.73	1.86	0.53	0.27	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	24.20	8.93	1.70	1.02	0.57	1.02	0.00	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	5.89	0.74	0.00	0.00	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	19.05	6.60	1.47	0.37	0.37	0.73	1.47	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	12.44	6.22	0.00	0.00	0.00	9.33	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	22.45	5.88	0.53	0.53	0.53	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	3.86	3.86	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	7.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	16.87	5.90	4.22	0.84	0.42	0.00	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	28.60	10.90	2.72	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	4.45	0.00	0.00	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	11.34	1.62	3.24	0.00	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	9.06	4.53	0.00	1.51	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	137.04	17.13	17.13	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	68.51	26.10	6.52	6.52	3.26	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	0.00	0.00	0.00	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	25.10	0.00	12.55	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	34.69	16.16	8.40	1.94	1.29	1.51	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	26.65	22.99	9.93	3.66	3.14	1.05	2.61	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	24.70	6.01	8.01	2.67	1.33	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	28.38	6.68	15.44	5.01	0.42	0.42	0.00	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	44.87	8.94	12.93	2.66	0.95	1.71	0.19	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	7.98	15.96	3.19	0.00	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.76	4.08	12.24	4.76	0.68	3.40	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	45.94	14.70	3.68	1.84	0.00	5.51	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	14.65	9.21	6.28	4.19	1.26	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	31.84	7.90	9.99	3.25	0.70	0.70	0.00	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.67	10.00	8.38	3.51	0.81	1.62	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	30.69	14.30	12.19	3.78	0.63	1.26	1.05	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	55.67	22.27	11.13	0.00	0.00	22.27	22.27	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	30.28	11.91	13.90	5.46	1.99	1.99	1.49	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	26.25	9.47	7.85	2.98	1.08	0.81	0.27	2.17
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	23.57	6.35	9.29	1.81	0.68	1.81	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	20.25	8.98	9.96	4.74	1.47	0.98	0.33	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	35.18	17.86	9.84	2.92	1.09	1.82	0.18	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.87	9.55	13.26	3.71	0.53	3.18	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	17.41	9.00	9.60	6.00	3.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	35.77	11.16	8.86	2.63	0.98	2.95	1.31	2.95
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	16.42	8.13	9.76	4.55	0.16	0.81	0.33	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	34.04	16.93	9.35	4.76	1.41	1.41	0.88	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	22.50	8.44	9.14	4.22	1.41	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.50	9.19	10.57	7.36	1.84	1.38	0.00	1.84
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	25.06	10.93	11.89	5.46	0.96	0.96	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	38.97	11.73	12.07	1.38	1.03	2.41	1.38	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	50.57	20.23	20.23	5.06	0.00	0.00	2.53	7.59
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	26.07	15.15	10.92	4.68	2.23	0.22	0.00	1.34
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.44	7.62	12.70	5.08	2.12	0.00	0.85	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	29.91	9.97	10.68	4.27	1.66	1.90	0.24	1.66
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	24.90	9.87	10.30	5.58	0.86	1.72	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	153.47	36.11	18.06	0.00	18.06	18.06	9.03	18.06
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	22.99	16.33	13.66	4.67	1.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.19	9.02	11.27	4.06	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	19.44	9.13	5.95	3.97	0.40	1.19	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	27.86	10.22	10.22	5.57	0.93	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	28.38	12.86	16.27	3.41	2.27	0.38	0.38	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	20.53	7.50	14.34	7.17	1.30	0.98	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	16.12	9.15	18.74	5.67	1.74	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	31.66	10.40	8.14	4.98	0.45	0.90	1.36	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	22.05	11.46	8.82	4.41	1.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	13.30	13.96	5.32	3.32	0.00	0.00	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	27.78	13.39	17.36	3.97	1.98	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	9.19	19.14	9.19	1.91	0.77	0.00	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	39.32	25.71	23.89	7.26	4.23	0.91	0.00	2.42
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	32.27	12.16	8.62	3.32	1.99	1.33	0.44	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	27.11	4.74	12.20	6.78	0.68	0.00	1.36	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	20.44	20.44	0.00	5.11	5.11	20.44	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	30.48	15.85	19.51	9.75	0.61	0.61	0.61	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	23.29	7.87	17.00	4.41	0.94	0.31	0.00	1.57
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	23.00	10.29	14.83	3.63	1.51	0.91	0.30	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	10.28	5.54	3.16	1.58	2.37	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	26.07	10.20	4.53	1.13	0.00	2.27	0.00	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	50.58	20.23	5.06	0.00	0.00	5.06	5.06	15.17
Myoblast, donor1	11241-116D8	33.29	19.01	7.21	4.10	0.99	3.85	0.25	0.87
Myoblast, donor2	11322-117D8	36.06	26.27	12.47	4.60	1.53	1.92	0.96	0.77
Myoblast, donor3	11398-118D3	43.89	21.69	11.10	2.35	1.51	3.87	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	37.50	41.01	7.30	4.52	4.38	0.44	1.90	1.46
Natural Killer Cells, donor1	11230-116C6	72.27	174.98	28.91	15.68	14.45	1.85	6.15	4.61
Natural Killer Cells, donor2	11311-117C6	55.18	142.03	19.30	15.98	10.86	0.60	13.87	8.14
Natural Killer Cells, donor3	11387-118C1	57.42	157.55	23.93	18.59	14.91	2.21	13.07	4.79
Neural stem cells, donor1	11275-116H6	88.92	46.82	11.25	4.72	2.54	3.63	2.18	0.00
Neural stem cells, donor2	11352-117H2	115.54	42.36	40.44	7.70	1.93	1.93	1.93	0.00
Neurons, donor1	11494-119E9	43.24	25.03	13.65	6.83	2.28	3.41	0.00	0.00
Neurons, donor2	11574-120E8	54.16	30.60	16.73	7.05	3.08	1.98	1.10	0.44
Neurons, donor3	11655-122E8	32.06	23.02	9.87	8.22	2.47	0.82	3.29	0.82
Neutrophils, donor1	11233-116C9	10.21	34.34	23.20	2.78	0.00	0.93	0.93	0.00
Neutrophils, donor2	11314-117C9	14.49	17.39	23.19	2.90	5.80	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	21.99	32.99	45.20	6.11	5.50	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	34.67	21.49	5.82	2.37	2.02	1.31	0.36	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	20.19	15.95	1.95	0.65	0.33	1.63	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	22.26	6.82	2.81	1.00	0.60	1.00	0.00	0.40
Olfactory epithelial cells, donor1	11933-125I7	27.53	18.17	6.74	4.13	2.34	0.55	2.34	1.38
Olfactory epithelial cells, donor2	11934-125I8	27.65	16.79	9.12	2.89	0.87	1.01	3.18	0.72
Olfactory epithelial cells, donor3	11935-125I9	26.11	15.55	7.38	3.75	1.02	2.04	1.70	0.79
Olfactory epithelial cells, donor4	11936-126A1	31.85	15.39	6.72	2.73	1.56	1.46	0.97	0.58
Oligodendrocyte - precursors, donor1	11496-119F2	51.76	11.43	4.81	1.20	3.01	1.20	1.20	0.00
Osteoblast - differentiated, donor1	11276-116H7	18.93	5.10	3.62	1.28	0.85	0.43	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	14.86	5.72	3.43	3.43	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	14.28	4.97	4.34	0.62	0.62	1.86	0.00	0.00
Osteoblast, donor1	11277-116H8	10.55	5.28	2.35	0.39	0.20	0.59	0.00	0.00
Osteoblast, donor2	11354-117H4	47.76	20.37	11.94	0.70	0.70	2.81	2.11	0.00
Osteoblast, donor3	11426-118G4	23.46	13.51	6.40	2.31	0.18	1.24	0.36	0.36
Pancreatic stromal cells, donor1	11249-116E7	44.39	21.65	8.17	2.44	1.43	1.94	1.01	0.34
Pericytes, donor1	11491-119E6	6.79	3.67	2.56	0.33	0.22	0.33	0.00	0.00
Pericytes, donor2	11571-120E5	9.96	2.94	2.94	0.45	0.23	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	8.95	4.68	2.03	0.61	0.41	1.22	0.00	0.20
Perineurial Cells, donor1	11499-119F5	47.58	25.20	7.46	2.83	1.13	1.81	0.68	0.45
Perineurial Cells, donor2	11579-120F4	35.42	18.59	4.51	1.93	1.20	1.47	0.09	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	60.24	128.45	26.14	11.16	9.88	0.64	2.23	2.23
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	34.77	82.27	20.57	13.96	7.10	0.24	1.96	3.67
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	37.27	93.96	20.45	14.75	10.87	0.91	1.29	1.94
Placental Epithelial Cells, donor1	11278-116H9	15.07	6.46	2.63	2.87	1.43	0.48	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	22.18	2.22	3.33	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	13.15	5.69	1.96	1.37	0.20	0.98	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.71	5.06	1.90	0.63	0.00	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	30.20	21.76	6.75	3.19	0.19	2.81	0.56	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	89.80	56.91	33.02	11.36	5.74	3.39	1.04	1.57
Preadipocyte - breast, donor2	11328-117E5	27.24	15.99	5.63	1.58	1.13	1.80	1.80	0.90
Preadipocyte - omental, donor1	11468-119C1	34.84	17.48	7.35	2.88	1.07	2.56	0.75	0.32
Preadipocyte - omental, donor2	11329-117E6	33.61	28.37	10.91	4.80	0.00	1.31	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	29.65	19.20	9.17	3.01	0.43	2.44	2.44	0.86
Preadipocyte - perirenal, donor1	11469-119C2	17.72	4.92	4.92	0.98	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	13.82	8.60	1.54	0.92	0.00	0.92	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	42.14	19.48	5.84	1.42	1.24	3.72	2.30	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	26.39	17.54	4.26	1.36	0.51	1.53	0.34	0.51
Preadipocyte - visceral, donor1	11280-116I2	53.56	24.03	6.33	2.70	1.77	4.75	1.49	0.19
Preadipocyte - visceral, donor2	11357-117H7	26.23	26.69	5.52	2.76	1.38	4.14	1.38	0.00
Preadipocyte - visceral, donor3	11429-118G7	28.53	10.55	3.24	0.94	1.04	0.84	0.31	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	29.11	20.21	8.75	4.53	3.17	0.75	0.91	0.45
Prostate Epithelial Cells, donor2	11331-117E8	23.83	9.89	6.36	0.95	0.81	2.30	0.68	0.27
Prostate Epithelial Cells, donor3	11404-118D9	33.07	9.12	11.76	3.98	1.53	0.92	3.00	0.61
Prostate Stromal Cells, donor1	11254-116F3	32.69	22.21	6.15	3.08	0.91	2.62	0.46	0.34
Prostate Stromal Cells, donor2	11332-117E9	29.23	22.77	6.45	2.87	1.08	1.79	1.97	0.54
Prostate Stromal Cells, donor3	11405-118E1	28.26	17.10	6.57	1.36	1.46	0.94	0.73	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	10.22	2.55	2.55	1.09	0.00	0.36	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	43.67	8.87	3.95	0.76	0.28	2.01	0.69	0.21
Renal Epithelial Cells, donor1	11517-119H5	12.17	7.61	3.55	0.51	0.00	1.01	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	10.67	4.98	2.13	0.71	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	53.04	13.44	5.29	1.48	0.85	1.80	1.06	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	8.17	2.72	2.72	1.36	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.48	2.83	3.77	0.94	0.13	0.67	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.08	12.43	3.33	2.44	0.89	2.44	1.55	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	3.99	0.67	1.33	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	13.65	5.06	3.08	0.44	0.22	0.88	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.76	7.52	5.02	0.00	0.63	0.63	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	5.83	1.11	1.11	0.83	0.28	0.83	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	19.33	7.78	2.95	0.54	0.27	0.81	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	9.28	2.11	3.80	0.00	0.42	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.19	5.59	2.70	0.96	0.19	0.00	0.19	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	37.34	13.22	7.78	1.56	1.56	0.78	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.95	9.38	4.83	1.42	0.57	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	2.06	4.12	1.03	1.03	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	26.35	16.56	4.27	1.51	0.25	1.51	0.00	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	51.45	52.12	11.49	4.68	3.21	1.60	1.20	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	68.79	74.15	49.14	15.19	8.93	1.79	3.57	3.57
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	128.79	112.28	39.63	17.06	6.05	4.95	14.31	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	111.37	78.89	43.50	16.82	2.90	4.06	11.60	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	81.40	39.79	33.03	10.01	4.55	2.73	0.52	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	53.92	49.55	22.24	10.03	6.36	1.49	4.47	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	85.55	92.13	28.44	12.72	7.14	2.79	0.78	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	83.48	51.85	23.82	10.17	5.33	2.48	2.60	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	58.39	50.00	17.13	9.67	4.08	0.82	5.71	1.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	74.89	71.88	27.74	15.49	5.32	2.31	5.32	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	56.68	31.35	27.93	8.49	3.01	1.78	0.68	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	63.69	44.47	21.33	10.74	4.69	1.97	4.54	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	76.87	78.66	30.28	15.95	6.09	2.33	0.00	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	59.96	39.02	24.96	10.90	3.30	0.72	1.72	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	53.66	51.08	20.28	7.94	3.76	2.04	2.79	2.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	53.99	61.96	27.66	14.38	7.08	1.77	3.32	1.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	53.53	31.74	24.28	10.51	1.91	2.10	0.96	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	51.98	50.03	23.10	9.22	6.06	2.14	1.77	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	96.21	116.50	28.94	20.48	6.76	3.95	4.89	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	55.21	35.57	25.88	13.54	3.32	2.26	0.66	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	61.91	52.95	24.72	10.22	5.16	2.14	2.82	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	71.04	74.66	27.31	12.41	7.64	3.63	6.11	2.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	50.73	33.96	25.52	9.72	5.34	1.60	0.85	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	49.61	51.58	20.18	7.57	3.36	1.68	4.20	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	57.59	60.67	28.37	14.87	5.47	2.22	6.49	2.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	47.04	29.36	25.71	13.49	4.19	1.28	0.73	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	56.66	50.28	24.04	8.95	4.78	1.96	4.78	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	64.88	65.01	28.21	11.42	8.46	1.88	3.09	2.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	59.44	33.97	26.65	12.74	3.30	2.12	0.94	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	53.37	49.60	21.23	11.71	4.56	2.98	4.37	2.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	54.49	64.31	27.59	15.67	7.48	1.40	4.21	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	58.47	32.97	22.39	9.75	3.53	1.66	0.41	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	51.10	53.31	22.12	10.62	3.10	2.43	1.55	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	54.94	59.32	30.29	16.29	6.89	1.88	4.80	1.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	68.37	38.63	28.67	12.65	2.96	2.29	1.08	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	50.41	49.90	27.93	13.96	5.96	1.70	1.36	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	56.30	60.54	27.38	15.23	5.78	2.51	5.78	1.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	67.40	31.98	24.24	14.44	3.27	2.24	2.58	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	56.24	46.77	27.85	10.84	5.49	1.10	1.10	1.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	64.68	58.28	26.43	11.00	5.75	2.13	4.10	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	53.17	31.87	24.37	9.88	2.56	1.36	1.87	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	61.11	56.08	19.53	7.55	6.66	1.04	3.40	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	54.64	63.71	26.39	11.73	7.20	2.40	1.33	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	58.21	41.07	33.46	10.92	3.32	1.38	0.55	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	65.00	51.19	20.48	4.76	5.48	0.95	3.57	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	74.77	84.45	32.05	18.94	9.07	2.22	3.83	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	52.83	42.47	23.92	9.61	3.58	1.04	1.13	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	80.70	74.06	25.50	13.97	6.64	2.10	9.78	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	72.23	76.16	30.83	15.41	8.46	2.12	3.63	2.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	59.11	39.65	21.17	10.16	5.02	0.86	1.96	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	193.44	316.43	99.27	59.68	27.07	6.84	2.47	4.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	76.05	87.01	38.94	18.86	7.91	1.83	3.65	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	55.46	43.70	30.14	9.95	4.52	1.81	0.90	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	70.80	79.84	34.38	15.38	9.50	2.04	5.88	3.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	97.95	163.25	59.91	28.76	16.47	3.29	4.19	5.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	84.19	47.23	33.77	15.82	6.02	2.13	0.35	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	63.82	69.37	40.98	19.21	13.87	1.49	2.77	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	94.35	149.04	58.29	39.66	18.63	1.80	13.22	2.40
Schwann Cells, donor1	11498-119F4	8.65	3.01	2.07	0.19	0.00	0.19	0.00	0.19
Schwann Cells, donor2	11578-120F3	27.22	17.01	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	22.57	10.08	1.75	1.31	0.22	2.41	0.44	0.00
Sebocyte, donor1	11220-116B5	24.65	8.76	4.38	1.10	0.55	3.29	0.00	0.00
Sebocyte, donor2	11301-117B5	14.25	10.57	3.22	1.38	1.84	0.46	0.00	0.00
Sebocyte, donor3	11378-118B1	13.81	5.77	3.09	0.82	0.21	0.41	0.21	0.21
Sertoli Cells, donor1	11255-116F4	21.54	18.22	9.94	1.66	3.31	6.63	1.66	0.00
Sertoli Cells, donor2	11333-117F1	45.19	31.07	2.82	5.65	0.00	0.00	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	33.52	14.16	5.01	2.82	1.41	0.70	0.35	0.09
Skeletal Muscle Cells, donor2	11358-117H8	5.06	4.34	2.17	0.72	0.72	0.00	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	16.72	9.20	1.67	1.67	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	41.16	15.40	13.82	3.93	1.57	1.41	0.16	0.79
Skeletal Muscle Cells, donor5	11455-119A6	35.08	18.73	7.13	2.53	1.19	1.64	0.15	1.19
Skeletal Muscle Cells, donor6	11459-119B1	43.40	18.62	11.08	3.39	1.23	1.85	0.31	1.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	53.43	35.41	14.74	3.53	2.65	2.14	0.38	1.51
Skeletal Muscle Satellite Cells, donor2	11321-117D7	39.10	27.97	12.13	3.42	2.43	2.71	1.43	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.30	31.55	10.91	4.46	1.98	2.88	0.79	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.69	16.18	5.22	2.36	1.26	0.59	0.51	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	20.27	5.79	4.34	4.34	0.00	1.45	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.52	5.09	3.44	0.41	0.00	1.10	0.00	0.00
Skin - palm, donor1	10286-104F7	45.66	42.98	42.98	8.06	10.74	0.00	32.23	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	25.23	4.61	5.77	1.15	0.29	1.15	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	145.58	26.17	132.50	12.27	0.82	10.63	0.82	6.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	22.20	5.45	4.93	1.82	0.26	0.91	0.39	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	41.84	13.76	8.20	2.09	1.39	2.50	0.83	0.97
Small Airway Epithelial Cells, donor2	11334-117F2	26.30	9.00	8.72	1.27	0.84	1.13	0.28	0.42
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	144.63	108.26	84.37	14.17	9.73	7.19	1.90	1.69
Small Airway Epithelial Cells, donor3	11406-118E2	36.35	11.99	10.42	3.37	0.90	1.42	0.52	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.35	4.94	2.78	1.23	0.62	1.54	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	46.69	28.01	21.12	6.00	1.11	1.33	0.89	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	20.57	4.11	2.35	0.00	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	10.61	5.75	1.55	3.31	0.44	1.10	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	12.21	3.94	0.79	0.00	0.39	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	26.27	9.27	3.86	0.00	0.77	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	28.02	21.02	4.00	4.00	0.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	17.03	7.85	2.53	1.60	0.53	1.20	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	25.49	19.28	5.76	2.66	1.33	1.77	1.55	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.15	11.91	10.75	5.89	0.90	1.28	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	43.63	18.23	4.88	2.60	0.98	1.95	0.00	1.30
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	31.30	20.38	8.27	3.25	1.18	1.48	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	29.04	17.94	10.11	3.56	1.85	1.71	0.28	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	4.23	1.95	1.14	0.49	0.00	0.49	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	26.79	13.40	4.57	3.35	0.91	3.04	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	18.94	8.08	2.02	0.76	0.51	0.51	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	14.78	2.38	1.91	0.95	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	43.36	21.38	7.37	2.80	1.62	2.21	0.59	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.78	22.38	6.46	1.51	1.29	2.15	0.65	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	36.11	22.46	9.34	2.41	1.57	2.62	0.73	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	12.37	4.18	1.39	0.46	0.31	0.77	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	9.70	4.31	2.16	1.08	0.00	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	16.14	4.48	2.69	1.20	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	9.22	4.44	3.07	0.34	0.34	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	47.27	30.63	10.13	3.46	3.22	1.49	0.63	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	34.72	9.96	10.47	2.42	0.60	1.81	0.91	0.40
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	33.45	16.38	4.55	2.28	0.68	1.82	0.91	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	8.45	3.02	1.21	0.60	0.00	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	59.61	28.35	14.04	6.09	2.38	5.30	1.85	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	46.21	13.98	7.86	1.73	1.20	2.00	0.27	1.20
Smooth Muscle Cells - Prostate, donor2	11335-117F3	27.80	20.79	7.89	2.63	1.00	2.88	2.00	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	24.10	17.25	3.80	1.52	0.51	1.78	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	29.40	10.40	3.02	1.36	0.30	1.06	0.00	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	12.00	10.50	1.50	0.00	0.00	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	2.58	5.17	7.75	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	17.21	5.58	2.79	0.00	0.47	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.16	7.07	1.51	3.53	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	13.79	5.01	1.25	2.19	0.31	0.31	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	3.24	0.88	2.65	0.59	0.29	0.29	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	55.23	22.58	6.50	2.33	1.58	3.75	0.08	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.49	13.08	2.34	0.93	0.47	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	15.11	6.91	2.30	0.43	0.00	0.58	0.14	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	16.83	7.65	3.57	1.02	1.02	1.02	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.79	3.20	1.50	0.19	0.00	0.19	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	46.53	13.83	8.52	1.96	0.98	2.52	0.28	0.56
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	37.12	11.23	3.27	0.67	0.59	1.34	0.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	3.33	0.48	0.95	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.77	6.12	1.22	0.73	0.00	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	41.32	11.27	5.97	1.77	0.44	3.31	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	31.60	12.58	4.10	1.17	0.59	1.76	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	31.49	13.99	9.33	2.33	0.78	1.55	2.14	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	23.80	10.05	7.40	1.85	0.79	1.32	2.38	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	42.40	14.51	5.58	1.12	0.37	1.86	2.98	1.86
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	32.70	12.58	9.34	1.80	0.72	0.72	1.80	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	24.13	5.96	3.69	2.56	0.57	1.42	1.14	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	32.30	9.85	6.70	0.79	0.79	2.36	3.15	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	29.71	14.22	7.62	1.27	0.00	3.05	2.29	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	29.95	17.57	11.58	2.00	1.60	1.20	3.99	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	23.83	10.03	6.27	2.09	0.42	0.00	0.84	2.09
Smooth muscle cells - airway, control, donor4	11969-126D7	34.38	12.83	7.79	3.67	0.92	1.83	0.46	1.38
Synoviocyte, donor1	11291-117A4	39.22	13.97	3.53	2.19	0.67	1.85	1.01	0.17
Synoviocyte, donor2	11368-117I9	29.67	18.27	5.70	1.51	1.34	0.00	1.01	0.50
Synoviocyte, donor3	11440-118H9	25.47	10.05	5.36	1.34	0.22	0.45	0.89	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	15.01	7.15	5.00	1.07	0.71	1.07	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	3.96	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	11.35	6.48	3.24	1.85	0.23	1.16	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	21.51	6.74	1.72	0.50	0.65	1.86	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	15.08	4.25	3.87	0.00	0.39	0.77	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	8.02	1.15	1.15	0.00	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	59.91	51.79	13.41	4.92	5.54	1.23	0.62	0.86
Urethra, donor2	10319-105A4	37.77	35.97	44.96	10.79	5.40	1.80	17.98	0.00
Urothelial Cells, donor1	11520-119H8	4.78	2.39	1.86	0.53	0.27	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	7.21	2.40	1.60	0.40	0.40	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	2.98	1.60	2.06	0.23	0.23	0.46	0.23	0.00
Urothelial cells, donor0	11216-116B1	50.37	6.02	3.79	0.89	0.45	1.34	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	50.72	30.25	27.58	4.45	2.67	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	35.74	32.88	24.30	5.72	0.00	1.43	0.00	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	17.11	43.81	11.64	0.68	1.37	1.37	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	35.47	59.57	20.66	9.99	7.23	0.34	1.03	1.72
Whole blood (ribopure), donor090325, donation2	12177-128I8	38.35	52.87	16.85	12.78	4.07	0.00	0.00	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	43.73	16.66	26.03	8.33	3.12	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	44.05	24.78	30.29	9.18	2.75	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	21.00	29.21	13.69	5.48	2.74	0.91	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	50.33	33.43	9.62	5.06	2.22	1.60	1.85	0.37
Wilms' tumor cell line:HFWT	10597-108E3	25.52	20.24	11.44	11.44	3.52	0.00	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	28.49	31.00	14.25	7.82	6.14	1.12	2.51	0.84
achilles tendon, donor2	10292-104G4	20.67	18.60	22.73	4.13	4.13	6.20	12.40	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	60.42	58.89	17.08	7.65	4.08	2.55	5.86	2.04
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	71.05	97.75	20.90	14.39	9.98	2.32	4.41	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	105.06	113.01	30.86	9.73	12.46	2.02	3.92	2.73
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	77.28	85.99	14.97	10.61	5.71	3.27	9.25	2.72
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	41.88	44.41	12.37	8.99	4.22	1.41	2.53	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	49.28	59.43	15.86	8.25	6.77	1.06	0.42	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	37.84	46.00	28.58	14.97	4.63	2.72	4.63	2.18
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	30.40	65.66	19.83	12.34	2.64	1.32	3.97	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	33.89	48.19	15.93	8.98	3.68	0.41	4.90	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	57.08	74.94	30.68	21.74	8.93	1.16	8.93	4.27
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	34.96	45.08	17.66	8.83	4.78	1.29	6.81	1.66
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	78.01	54.61	31.20	3.90	3.90	0.00	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	47.17	46.01	12.32	4.88	3.49	1.86	3.49	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	61.10	65.50	17.61	12.95	5.95	2.59	5.70	2.85
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	54.07	55.82	16.66	8.77	7.01	2.05	6.72	2.92
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	31.60	43.22	22.31	9.30	7.90	0.46	2.32	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	31.67	37.84	10.69	6.17	1.23	0.00	3.29	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	19.03	15.65	12.28	4.30	1.84	0.92	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	34.99	41.39	14.51	4.69	3.84	2.99	2.56	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	47.62	52.17	16.38	7.58	3.64	2.12	1.21	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	41.64	55.36	15.16	7.22	5.54	1.44	1.20	0.96
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	32.74	28.51	13.59	8.02	2.00	1.34	1.78	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	33.02	37.02	12.34	7.00	2.33	1.33	1.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	61.32	31.59	37.16	7.43	3.72	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	45.95	50.47	18.46	9.79	2.26	1.88	1.88	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	52.77	60.19	17.88	13.08	5.67	3.49	0.87	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	50.61	41.24	44.99	13.12	1.87	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	37.21	29.67	8.24	4.71	2.83	1.18	0.94	0.47
adipose tissue, adult, pool1	10010-101C1	42.04	24.51	6.67	1.86	1.71	0.93	0.62	0.93
adipose, donor1	10184-103D4	112.00	31.08	32.25	4.10	3.52	1.76	12.31	9.97
adipose, donor2	10185-103D5	49.47	18.65	34.47	6.08	3.24	0.41	1.62	2.43
adipose, donor3	10186-103D6	56.64	23.69	32.95	7.08	3.00	1.63	3.00	1.36
adipose, donor4	10187-103D7	38.14	21.67	19.94	13.00	0.87	1.73	4.33	3.47
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	35.67	46.24	22.73	5.52	4.89	2.84	1.58	0.32
adrenal gland, adult, pool1	10081-102A9	10.91	29.10	18.19	10.91	3.64	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.89	44.29	13.87	3.60	3.47	1.60	0.67	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	40.37	32.51	6.07	4.64	2.86	3.22	2.14	1.07
amniotic membrane cells, donor1	12235-129G3	38.72	22.72	13.45	3.25	2.55	1.39	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	36.85	29.08	12.17	4.06	2.03	2.37	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	34.47	17.09	15.32	3.54	0.88	1.47	0.88	1.47
amygdala - adult, donor10196	10167-103B5	77.08	18.97	18.97	2.37	1.19	2.37	7.11	0.00
amygdala, adult, donor10252	10151-102I7	67.72	51.91	23.12	12.37	4.06	2.84	6.69	0.61
amygdala, newborn, donor10223	10360-105E9	35.18	14.52	14.20	8.39	1.29	2.90	2.58	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	41.89	28.65	9.80	4.46	4.97	1.53	1.02	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	28.46	35.74	13.46	10.81	3.31	0.44	3.31	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	83.84	114.57	29.06	16.70	12.36	3.01	12.03	2.67
aorta, adult, pool1	10052-101G7	26.48	36.48	13.73	3.92	2.75	0.59	0.98	0.39
appendix, adult	10189-103D9	47.35	53.56	31.44	12.42	8.54	0.78	0.39	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	38.52	66.38	28.20	9.29	7.57	1.72	3.44	2.41
artery, adult	10190-103E1	43.48	21.74	16.30	6.79	1.36	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	87.21	53.02	11.59	8.84	6.66	3.04	1.01	2.32
b cell line:RPMI1788	10427-106D4	44.02	58.74	29.74	8.77	11.30	2.38	1.19	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	43.00	18.31	8.60	3.05	1.66	1.94	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	27.19	26.49	7.34	5.36	4.07	1.09	0.40	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	46.87	31.63	7.70	8.70	4.35	1.67	1.17	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	21.81	27.40	17.34	9.51	7.83	0.00	3.91	2.80
bladder, adult, pool1	10011-101C2	45.09	30.75	14.12	2.39	4.45	0.87	0.43	0.65
blood, adult, pool1	10053-101G8	6.64	15.50	4.43	2.21	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	46.24	11.99	11.13	0.00	0.86	2.57	0.00	0.00
bone marrow, adult	10192-103E3	43.86	34.42	10.80	2.02	0.67	0.00	7.42	1.35
brain, adult, donor1	10084-102B3	27.68	20.50	17.43	4.10	1.03	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	56.46	23.16	10.91	2.78	3.79	2.34	0.78	1.00
brain, fetal, pool1	10085-102B4	32.06	34.73	21.37	8.01	10.69	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	16.85	27.75	24.45	2.64	4.29	0.66	2.97	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	50.93	58.42	26.34	4.49	4.62	1.75	0.62	0.62
breast, adult, donor1	10080-102A8	37.88	22.73	9.47	6.94	3.79	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	21.72	22.36	6.10	1.40	2.16	1.40	1.65	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	42.67	34.63	18.24	6.80	5.26	3.09	4.64	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	39.60	27.86	7.37	2.30	2.99	3.22	1.61	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	28.32	28.81	9.20	3.15	2.42	0.73	2.42	1.45
carcinoid cell line:NCI-H1770	10703-109H1	71.47	76.64	47.96	8.46	19.28	5.64	6.58	5.17
carcinoid cell line:NCI-H727	10735-110B6	23.19	37.41	13.34	9.19	5.91	1.75	0.98	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	46.90	44.05	24.72	5.39	3.80	2.22	4.44	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	64.42	83.31	25.29	16.50	7.19	2.66	7.72	3.73
caudate nucleus - adult, donor10196	10177-103C6	90.95	25.33	40.30	8.06	4.61	2.30	6.91	0.00
caudate nucleus, adult, donor10252	10164-103B2	63.58	38.15	20.92	9.37	3.85	2.01	4.02	0.67
caudate nucleus, adult, donor10258	10379-105H1	55.78	25.22	16.05	3.06	4.58	3.06	7.64	1.53
caudate nucleus, newborn, donor10223	10354-105E3	42.85	13.92	16.48	11.72	0.37	3.66	0.73	0.37
cerebellum - adult, donor10196	10173-103C2	142.75	107.79	43.70	8.74	11.65	5.83	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	122.56	190.45	47.40	12.17	11.53	8.33	5.98	1.07
cerebellum, adult, pool1	10083-102B2	41.05	51.40	13.11	3.79	3.45	1.72	4.48	0.69
cerebellum, newborn, donor10223	10357-105E6	95.48	59.78	31.55	14.95	8.30	4.98	6.64	0.83
cerebral meninges, adult	10188-103D8	50.18	18.15	14.37	3.53	3.78	1.51	0.76	0.76
cerebrospinal fluid, donor2	10294-104G6	15.35	7.31	13.89	3.65	2.19	0.73	7.31	1.46
cervical cancer cell line:D98-AH2	10552-107I3	82.82	60.82	24.44	13.23	6.76	2.16	1.58	2.01
cervical cancer cell line:ME-180	10553-107I4	32.81	27.01	5.47	3.65	3.15	0.66	0.50	0.00
cervix, adult, pool1	10013-101C4	67.19	52.71	18.37	7.35	7.14	0.94	1.47	1.47
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	61.03	57.41	15.19	7.80	6.83	2.37	0.84	1.39
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	5.23	9.14	6.53	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	63.01	42.63	34.55	13.79	10.94	0.87	1.49	0.87
choriocarcinoma cell line:SCH	10785-110H2	38.07	22.55	10.84	4.81	3.57	1.48	1.48	0.86
choriocarcinoma cell line:T3M-3	10618-108G6	34.87	40.79	41.98	16.37	8.54	0.95	1.66	0.24
chorionic membrane cells, donor1	12238-129G6	32.77	20.23	9.40	1.99	2.28	1.71	0.28	0.28
chorionic membrane cells, donor2	12239-129G7	44.94	18.49	4.87	2.09	1.39	1.39	0.60	0.40
chorionic membrane cells, donor3	12240-129G8	31.87	17.58	7.14	2.75	1.10	0.55	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	33.32	31.30	11.11	8.08	1.01	1.01	5.05	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	26.89	38.23	19.98	9.99	2.88	0.58	2.50	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	58.92	73.92	33.16	17.74	6.34	2.53	2.75	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	59.06	44.68	16.44	12.07	4.37	1.54	1.54	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	66.27	47.65	19.35	15.00	2.18	2.90	1.45	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	64.54	52.94	21.79	13.85	4.48	2.24	1.63	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	76.85	69.20	21.20	20.02	4.71	3.53	3.83	2.36
chronic myelogenous leukemia cell line:KU812	10409-106B4	101.12	95.91	51.60	28.93	11.73	2.35	2.09	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	36.57	34.97	13.71	4.11	3.20	1.37	5.03	2.06
clear cell carcinoma cell line:TEN	10636-108I6	30.19	45.81	8.68	4.68	2.78	2.26	2.26	0.87
colon carcinoma cell line:CACO-2	10513-107D9	24.53	28.37	6.22	4.39	2.75	0.92	0.37	0.37
colon carcinoma cell line:COLO-320	10420-106C6	107.56	43.33	24.33	6.08	7.98	3.04	1.52	0.00
colon, adult, donor1	10082-102B1	22.61	33.32	10.71	5.95	8.33	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	52.05	32.43	12.93	4.23	3.88	1.88	0.71	1.06
colon, fetal, donor1	10070-101I7	25.96	33.99	24.10	14.83	2.47	1.24	2.47	2.47
common myeloid progenitor CMP, donor1	12130-128D6	100.84	178.76	146.67	45.84	22.92	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	50.07	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	82.44	69.69	15.72	12.32	5.10	5.52	0.85	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	44.68	47.69	6.64	6.64	2.72	1.36	0.91	0.60
cord blood derived cell line:COBL-a untreated	10449-106F8	48.65	48.37	9.87	5.50	4.94	0.99	1.97	0.71
corpus callosum, adult, pool1	10042-101F6	69.65	50.64	21.12	5.86	8.29	3.54	0.22	0.88
cruciate ligament, donor2	10295-104G7	30.80	29.18	29.18	5.67	6.48	0.81	8.10	1.62
diaphragm, fetal, donor1	10069-101I6	31.30	28.89	15.25	8.03	4.01	0.00	3.21	0.80
diencephalon, adult	10193-103E4	40.08	20.88	12.00	3.60	2.16	3.12	2.88	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	32.83	67.74	18.60	11.71	7.81	0.92	11.25	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	51.03	42.06	14.62	7.44	5.39	1.54	0.51	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	37.79	36.59	15.41	3.37	3.37	5.78	3.85	1.93
ductus deferens, adult	10196-103E7	47.34	47.84	24.42	7.48	5.48	0.50	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	36.01	46.09	21.60	21.60	2.88	1.44	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	41.20	42.67	26.48	8.09	6.62	0.74	3.68	2.94
dura mater, adult, donor1	10041-101F5	54.26	81.35	30.56	4.96	8.59	2.06	0.66	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	75.95	56.18	17.77	25.76	4.22	9.77	1.78	0.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	51.73	47.00	12.90	11.89	2.87	9.89	1.00	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	30.21	17.27	6.78	1.85	2.47	0.00	3.70	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	28.15	21.49	4.84	0.91	1.51	0.91	0.91	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	33.04	20.69	4.94	4.94	1.85	0.93	0.93	0.62
embryonic pancreas cell line:2C6	10603-108E9	31.52	17.08	5.25	1.31	1.31	0.00	0.00	2.63
endometrial carcinoma cell line:OMC-2	10497-107C2	34.86	42.57	17.43	6.03	4.69	1.34	1.01	2.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	62.34	32.08	7.25	4.71	5.07	1.45	5.07	2.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	26.37	20.42	6.75	2.73	0.80	0.80	2.09	1.61
epidermoid carcinoma cell line:A431	10426-106D3	56.47	31.12	11.89	3.67	3.22	1.89	0.78	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	44.21	28.71	11.88	5.17	4.95	1.76	0.66	0.55
epididymis, adult	10197-103E8	43.12	43.54	33.07	9.42	8.37	1.88	2.09	3.14
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	42.76	40.27	7.98	4.26	3.90	0.89	2.66	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	22.81	16.91	3.54	3.54	3.54	0.79	3.15	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	41.02	58.71	10.62	11.40	3.67	1.70	1.83	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	47.04	68.60	10.33	13.98	5.71	1.48	3.44	0.89
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	43.69	57.14	11.76	11.31	5.15	2.46	2.91	0.78
esophagus, adult, pool1	10015-101C6	44.91	22.62	8.81	2.12	2.02	0.85	0.32	0.21
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	81.53	76.14	23.29	10.39	10.90	2.00	0.50	0.38
eye - muscle inferior rectus, donor1	10272-104E2	43.46	43.46	36.22	21.73	9.66	2.41	14.49	2.41
eye - muscle lateral, donor2	10298-104H1	21.04	16.83	4.21	6.31	0.00	0.00	6.31	0.00
eye - muscle medial, donor2	10299-104H2	14.88	19.35	19.35	4.46	2.98	0.00	11.91	0.00
eye - muscle superior, donor2	10297-104G9	16.05	25.22	20.64	3.44	2.29	1.15	4.59	0.00
eye - vitreous humor, donor1	10268-104D7	16.03	20.40	34.98	5.83	10.20	1.46	2.91	0.00
eye, fetal, donor1	10054-101G9	36.86	19.32	12.20	4.07	2.54	1.53	1.27	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	25.13	21.29	8.59	2.69	1.92	0.26	0.90	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	33.24	20.18	13.06	3.80	2.61	1.66	1.66	0.71
frontal lobe, adult, pool1	10040-101F4	75.90	47.57	22.80	4.03	5.91	3.57	0.75	0.28
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	59.15	82.87	29.42	11.11	10.21	2.70	10.51	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	63.55	28.53	12.62	2.10	2.83	2.19	0.18	0.46
gall bladder, adult	10198-103E9	31.39	31.87	22.69	6.52	4.35	0.72	0.72	0.97
gamma delta positive T cells, donor1	11937-126A2	73.55	88.58	26.31	10.74	10.20	0.54	0.54	2.68
gamma delta positive T cells, donor2	11938-126A3	66.48	87.02	24.28	7.10	8.22	2.24	0.75	5.60
gastric adenocarcinoma cell line:MKN1	10614-108G2	35.70	30.42	10.77	2.53	1.90	1.90	2.75	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	44.49	52.03	11.60	7.74	4.64	0.97	1.93	2.13
gastric cancer cell line:AZ521	10549-107H9	55.91	44.76	11.48	6.07	3.93	4.43	0.49	0.98
gastric cancer cell line:GSS	10560-108A2	20.13	37.52	5.49	7.32	6.41	1.83	1.83	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	51.40	71.96	29.24	23.53	5.71	2.97	4.80	1.83
giant cell carcinoma cell line:LU65	10487-107B1	44.06	28.34	18.36	9.06	5.16	1.38	2.41	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	70.26	33.45	15.54	1.96	3.22	4.34	0.70	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.93	21.45	14.72	8.23	5.49	1.50	1.75	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	54.57	27.34	5.59	2.32	2.01	1.16	1.16	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	54.07	27.25	6.32	2.95	2.67	1.54	1.97	0.14
glioblastoma cell line:T98G	10485-107A8	48.79	58.28	6.95	3.31	2.98	2.21	3.20	0.55
glioma cell line:GI-1	10413-106B8	38.37	48.62	11.72	7.32	5.86	3.51	1.17	0.59
globus pallidus - adult, donor10196	10175-103C4	81.64	26.97	34.26	2.92	2.92	5.10	2.92	1.46
globus pallidus, adult, donor10252	10161-103A8	93.98	80.31	26.36	12.45	7.32	3.66	4.64	0.98
globus pallidus, adult, donor10258	10367-105F7	61.61	30.12	24.65	16.43	6.85	0.00	1.37	5.48
globus pallidus, newborn, donor10223	10364-105F4	36.24	17.59	8.53	12.26	2.13	3.20	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	78.31	88.10	85.65	46.50	7.34	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	54.64	0.00	10.93	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	10.45	20.91	0.00	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	37.76	21.76	13.44	4.48	1.60	0.64	1.60	1.92
hIPS +CCl2, biol_rep1	14383-156B9	41.32	14.69	30.30	6.89	0.92	1.38	2.75	0.00
hIPS +CCl2, biol_rep2	14384-156C1	44.81	17.38	32.01	8.69	0.91	0.91	1.37	1.83
hIPS +CCl2, biol_rep3	14385-156C2	36.71	16.75	32.20	3.86	1.93	2.58	4.51	0.00
hIPS, biol_rep1	14380-156B6	25.87	10.06	21.56	5.75	1.44	1.44	0.00	0.00
hIPS, biol_rep2	14381-156B7	26.06	10.97	26.75	6.17	0.69	0.00	1.37	0.00
hIPS, biol_rep3	14382-156B8	58.48	12.14	19.86	2.21	1.10	4.41	4.41	1.10
hairy cell leukemia cell line:Mo	10712-109I1	39.65	45.69	14.65	4.60	3.16	1.44	4.88	1.15
heart - mitral valve, adult	10205-103F7	47.24	27.80	15.55	8.37	3.29	1.49	0.00	1.20
heart - pulmonic valve, adult	10206-103F8	56.22	28.76	15.17	3.66	3.92	1.31	2.88	1.57
heart - tricuspid valve, adult	10207-103F9	41.63	21.65	23.31	17.49	4.16	0.83	2.50	2.50
heart, adult, diseased post-infarction, donor1	10050-101G5	18.77	28.98	8.37	1.63	3.26	0.41	1.02	0.61
heart, adult, diseased, donor1	10051-101G6	11.50	10.22	5.54	0.85	1.70	0.85	0.00	0.00
heart, adult, pool1	10016-101C7	54.27	9.20	5.98	1.84	1.61	1.15	0.23	0.00
heart, fetal, pool1	10046-101G1	78.96	43.84	21.56	9.34	7.29	1.33	0.72	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	31.16	16.97	11.11	4.32	0.31	0.62	0.62	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	32.11	45.19	29.73	2.38	0.00	4.76	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	56.79	60.66	11.60	10.17	3.31	3.09	2.98	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	55.35	57.17	13.23	9.83	3.03	3.16	3.16	0.97
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	68.11	60.33	15.87	12.43	3.54	3.64	3.33	0.91
hepatoma cell line:Li-7	10484-107A7	35.70	30.03	3.89	5.45	3.45	1.45	1.00	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	34.17	33.87	18.89	6.73	4.92	1.31	2.21	0.90
hippocampus - adult, donor10196	10169-103B7	61.51	14.19	27.44	3.79	1.89	4.73	3.79	1.89
hippocampus, adult, donor10252	10153-102I9	74.90	51.84	20.82	7.55	3.67	2.65	4.90	1.63
hippocampus, adult, donor10258	10374-105G5	54.77	15.44	17.93	1.00	1.00	1.99	1.99	0.50
hippocampus, newborn, donor10223	10363-105F3	33.84	15.51	20.09	9.52	2.82	2.47	1.41	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	63.48	31.13	46.39	15.26	3.66	3.05	1.83	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	48.70	27.69	29.45	19.05	4.91	0.98	2.36	1.37
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	46.97	22.09	33.77	15.74	3.81	2.03	1.52	3.05
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	72.17	22.55	30.45	6.77	3.95	2.82	1.69	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	57.06	35.12	35.37	4.91	2.07	2.07	5.94	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	86.17	26.19	32.65	9.49	3.80	2.28	1.90	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	86.13	23.36	42.04	11.09	4.38	3.50	2.92	2.63
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	68.08	28.01	45.67	10.56	6.03	2.59	3.88	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	70.07	25.44	35.87	15.85	3.34	1.67	2.09	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	78.85	27.47	23.21	10.42	4.50	2.60	0.95	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	54.32	31.66	19.45	9.80	3.38	1.61	1.77	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	67.33	38.38	22.22	12.12	4.04	2.69	0.67	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	44.44	23.79	33.64	16.59	5.63	0.47	2.50	1.41
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	45.69	19.16	31.44	16.21	2.46	0.98	4.91	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	54.98	27.93	27.93	8.73	6.11	1.75	5.24	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	79.04	42.76	39.71	7.64	4.96	3.25	3.05	1.34
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	78.93	29.65	36.19	9.16	1.74	1.31	2.62	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	93.46	26.99	30.49	7.50	3.50	0.50	5.00	2.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	52.75	23.17	27.32	7.16	3.96	2.07	1.88	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	60.48	30.01	38.20	8.18	0.91	2.27	0.00	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	64.53	18.48	20.67	3.13	0.94	2.51	2.51	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	50.95	24.17	21.23	4.74	1.47	1.47	1.47	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	54.58	24.10	17.71	5.52	1.45	1.45	0.58	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	55.60	13.75	22.12	6.28	1.49	0.30	3.89	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	43.78	31.04	28.08	17.74	4.25	1.48	2.77	2.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	43.08	28.81	43.08	16.83	5.14	1.14	2.57	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	58.39	31.03	31.03	13.07	4.49	2.04	4.49	8.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	62.67	24.29	25.00	8.80	4.93	3.17	1.06	2.46
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	61.13	27.24	27.56	6.97	1.90	1.90	3.48	1.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	68.09	24.21	20.88	6.05	3.93	0.61	3.33	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	66.19	22.24	27.92	7.76	2.59	1.03	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	54.46	23.91	23.25	11.95	1.99	0.66	0.66	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	55.41	25.65	18.73	6.41	4.10	1.80	1.54	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	55.73	23.52	14.57	7.16	2.56	1.79	1.28	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	56.03	37.10	29.53	12.87	1.51	0.76	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	61.83	20.84	14.45	10.42	3.36	1.34	2.02	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	48.78	26.57	37.43	20.05	3.14	1.45	1.69	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	55.71	29.86	32.09	17.38	2.67	1.78	1.78	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	57.07	27.81	30.73	14.63	2.93	1.95	2.93	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	72.43	30.87	29.34	5.20	3.06	2.14	0.92	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	257.01	71.57	35.79	6.51	13.01	9.76	13.01	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	95.31	31.11	21.84	5.30	3.31	3.97	1.99	2.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	59.66	24.63	36.67	6.57	4.38	2.74	1.09	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	72.01	24.25	28.59	9.05	3.98	3.26	2.17	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	60.85	17.44	23.13	6.76	2.14	2.85	2.49	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	66.83	39.38	14.32	9.55	1.19	4.77	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	95.88	34.53	23.29	6.91	4.47	2.44	0.95	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	44.99	18.32	11.31	3.50	1.62	0.54	2.16	1.35
immature langerhans cells, donor1	11904-125F5	57.15	42.13	30.51	7.51	3.63	1.94	0.97	1.45
immature langerhans cells, donor2	11905-125F6	40.40	51.49	56.24	16.63	9.51	0.79	0.00	0.79
insula, adult, pool1	10039-101F3	65.20	50.91	23.66	4.92	5.02	2.93	0.28	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	20.81	22.11	3.25	1.63	1.63	0.33	1.63	0.33
kidney, adult, pool1	10017-101C8	46.96	27.94	8.81	3.60	2.40	2.10	0.60	0.80
kidney, fetal, pool1	10045-101F9	48.38	51.71	24.62	8.98	6.51	0.85	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	77.26	70.02	45.45	21.73	9.09	1.70	1.42	1.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	17.00	14.52	3.32	4.70	3.32	0.97	1.11	0.55
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	27.71	19.27	10.46	6.79	5.14	0.73	0.55	0.55
left atrium, adult, donor1	10079-102A7	20.70	11.99	5.99	2.18	1.63	0.00	2.18	0.00
left ventricle, adult, donor1	10078-102A6	19.72	4.05	4.05	1.52	0.00	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	40.77	30.10	14.77	4.92	2.46	1.37	2.74	0.55
leiomyoma cell line:10964C	10569-108B2	12.93	6.83	3.23	0.72	0.00	1.08	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	15.22	7.07	2.17	0.54	0.00	4.35	0.00	0.00
leiomyoma cell line:15425	10571-108B4	25.25	13.60	2.91	0.49	0.49	2.19	0.73	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	6.35	12.70	6.35	0.00	6.35	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	49.14	38.69	13.59	4.18	4.18	0.00	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	104.72	139.43	88.66	46.16	12.63	3.42	10.03	5.55
liposarcoma cell line:KMLS-1	10782-110G8	31.24	23.74	10.00	3.91	0.78	1.87	0.78	0.62
liposarcoma cell line:SW 872	10726-110A6	32.53	23.03	8.29	3.17	2.80	0.97	0.49	0.49
liver, adult, pool1	10018-101C9	23.99	20.58	7.29	5.51	1.46	1.46	0.16	0.49
liver, fetal, pool1	10086-102B5	12.23	16.93	7.53	6.58	2.82	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	54.25	27.56	19.25	6.42	3.79	3.35	3.94	0.15
locus coeruleus, adult, donor10252	10165-103B3	62.01	44.85	19.19	8.12	4.43	3.88	3.51	0.92
locus coeruleus, adult, donor10258	10375-105G6	36.96	15.80	14.67	3.10	0.85	0.85	0.56	0.85
locus coeruleus, newborn, donor10223	10362-105F2	63.09	22.71	13.46	9.25	2.10	2.52	3.36	0.42
lung adenocarcinoma cell line:A549	10499-107C4	13.98	12.59	3.46	2.77	0.83	0.28	0.00	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	70.32	26.20	11.03	2.76	2.76	2.76	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	49.83	45.87	15.95	4.22	4.09	3.69	1.85	0.66
lung, adult, pool1	10019-101D1	39.69	32.37	11.34	2.84	2.84	0.83	0.59	0.35
lung, fetal, donor1	10068-101I5	123.58	63.36	61.65	16.55	5.42	2.28	0.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	33.91	24.74	15.12	5.96	3.67	0.00	7.33	0.92
lymph node, adult, donor1	10077-102A5	15.15	24.14	7.57	4.26	5.68	0.00	2.37	0.00
lymphangiectasia cell line:DS-1	10727-110A7	23.67	37.70	19.51	10.74	5.70	0.66	1.53	1.32
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	51.62	69.73	24.15	15.70	6.04	0.75	2.26	1.96
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	75.61	56.07	17.84	16.14	3.40	3.40	1.70	0.00
mature adipocyte, donor1	12231-129F8	54.17	20.87	20.42	6.22	3.11	0.89	0.44	0.00
mature adipocyte, donor2	12232-129F9	54.79	31.75	18.26	9.75	3.32	0.42	0.00	0.00
mature adipocyte, donor3	12233-129G1	56.18	32.00	16.12	4.50	2.84	1.90	0.24	0.24
mature adipocyte, donor4	12234-129G2	60.54	43.96	13.16	6.05	1.05	1.32	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	71.24	83.63	38.84	17.15	11.44	2.86	0.48	1.19
medial frontal gyrus - adult, donor10196	10170-103B8	75.58	30.46	22.56	5.64	1.13	1.13	6.77	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	70.25	54.80	25.01	8.09	3.13	3.49	6.62	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	55.91	13.03	15.25	2.86	0.32	3.49	5.40	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	49.47	17.49	14.50	4.69	2.13	2.99	1.28	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	67.33	36.11	21.26	4.89	5.91	5.06	4.89	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	70.88	65.37	29.71	9.97	4.46	1.70	8.49	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	69.35	17.34	11.56	3.85	1.93	7.71	1.93	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	258.37	129.18	86.12	14.35	14.35	14.35	100.48	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	47.38	17.59	17.59	7.18	1.79	3.23	2.15	0.36
medulla oblongata - adult, donor10196	10174-103C3	57.76	19.47	20.77	0.65	3.89	1.95	7.79	0.00
medulla oblongata, adult, donor10252	10155-103A2	63.62	54.03	21.36	6.50	4.49	4.02	2.01	0.62
medulla oblongata, adult, pool1	10038-101F2	50.28	33.39	16.49	5.31	5.47	2.45	0.24	0.24
medulla oblongata, newborn, donor10223	10361-105F1	45.13	17.36	11.11	10.42	3.12	2.43	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	64.21	97.86	52.70	33.65	13.51	3.32	7.75	1.33
medulloblastoma cell line:ONS-76	10759-110E3	33.75	32.28	12.35	4.65	1.71	2.20	1.59	0.24
melanoma cell line:COLO 679	10514-107E1	29.32	30.33	6.47	5.03	2.44	1.15	1.29	0.14
melanoma cell line:G-361	10465-106H6	33.66	29.32	3.26	2.17	2.17	0.81	1.90	0.81
meningioma cell line:HKBMM	10691-109F7	20.98	11.04	4.34	2.53	1.63	0.18	0.54	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	81.95	82.83	29.08	19.39	12.34	0.88	7.05	3.52
merkel cell carcinoma cell line:MS-1	10844-111E7	69.21	95.65	39.66	25.40	13.74	3.11	1.81	5.18
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.45	19.18	4.60	2.15	0.31	0.77	0.61	1.23
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.72	15.27	3.82	1.82	0.91	0.55	0.73	1.45
mesenchymal precursor cell - adipose, donor3	11749-123G3	23.60	16.98	4.14	1.66	0.00	2.48	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	29.08	9.13	3.37	1.12	1.12	1.26	0.56	0.42
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	28.11	12.90	5.78	1.16	0.77	0.96	0.77	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	27.07	18.74	6.25	2.78	2.08	2.08	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	17.85	9.44	5.15	2.57	0.34	1.37	0.00	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	33.70	13.11	7.71	2.53	1.15	1.04	0.35	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	26.79	17.11	6.63	1.99	1.46	1.19	0.27	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	30.38	13.50	5.81	1.89	1.08	1.49	0.81	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	35.85	12.52	6.40	3.27	0.71	2.99	0.71	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	23.05	17.13	6.26	3.29	1.32	1.65	1.32	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	36.81	15.64	7.47	2.08	1.25	2.49	0.83	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	32.12	13.96	1.05	1.40	0.70	1.40	2.79	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	28.99	11.84	4.29	1.63	1.43	1.63	0.20	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	29.48	18.33	8.27	4.31	1.80	2.52	2.16	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	26.17	8.07	3.62	1.03	1.14	0.62	0.00	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	24.17	14.14	8.21	1.37	1.37	2.28	0.91	1.14
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	54.54	15.52	13.01	4.62	2.10	5.03	0.84	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	36.46	18.83	7.47	3.29	1.34	2.09	0.45	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	30.90	12.52	4.20	1.84	1.31	1.23	0.70	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	38.66	20.99	7.36	1.47	1.47	2.58	1.10	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	36.06	17.74	12.02	6.01	0.57	3.15	1.43	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	37.05	27.37	4.21	2.95	0.84	1.26	2.53	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	27.86	12.79	8.22	2.28	0.46	0.91	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	26.09	12.53	5.88	2.81	2.05	1.79	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	37.17	17.28	5.50	1.57	0.79	1.31	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.34	14.17	4.31	1.54	1.23	1.23	0.62	1.54
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	26.36	14.12	5.65	0.47	0.71	2.59	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	28.77	13.88	6.09	1.35	0.68	2.03	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	26.72	13.75	3.93	2.75	1.18	1.96	1.57	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	24.56	13.44	6.02	1.85	0.93	2.32	1.85	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	31.73	16.44	8.94	2.31	1.44	1.44	1.15	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	31.68	10.71	8.25	1.56	1.12	1.56	0.89	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	30.52	14.90	6.25	1.20	1.92	2.88	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	30.80	10.27	6.60	2.20	0.73	1.47	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.17	10.74	6.71	3.02	0.34	1.01	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	22.93	14.33	4.50	1.23	1.23	0.82	0.82	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	32.22	10.31	6.01	3.01	0.86	2.58	0.43	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	30.08	27.34	5.47	5.47	0.00	5.47	5.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	15.49	0.00	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	26.63	14.62	6.17	1.62	0.32	1.30	1.95	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	27.64	16.00	2.91	4.36	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	22.92	11.19	5.86	2.13	0.53	1.60	1.60	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	23.72	14.72	12.27	1.64	1.64	2.45	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	27.21	9.33	7.77	2.33	0.78	1.55	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	16.79	8.39	8.39	4.20	0.00	4.20	0.00	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	19.87	15.90	3.97	0.99	0.00	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	4.77	4.77	4.77	4.77	4.77	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.94	11.27	11.27	0.59	1.19	1.19	2.37	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	13.40	13.40	9.75	1.22	2.44	0.00	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	10.77	5.70	2.53	1.27	1.27	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	34.15	15.18	8.28	1.03	0.00	0.69	1.03	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	15.04	12.90	4.30	2.15	2.15	4.30	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	15.97	11.98	7.98	0.00	3.99	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	17.22	13.78	10.33	0.00	3.44	3.44	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.56	13.04	6.52	2.44	2.04	2.04	2.44	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	23.04	17.48	7.94	1.59	0.79	0.00	1.59	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	18.28	11.79	7.66	2.95	2.36	1.18	2.36	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	25.25	19.01	9.04	4.68	0.94	0.31	1.56	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	25.40	14.70	9.36	5.35	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	23.65	20.11	4.73	4.73	1.18	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	28.25	30.82	5.14	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	34.42	11.01	6.88	5.51	2.75	0.00	3.44	2.07
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	24.74	12.86	8.41	4.95	2.47	0.99	1.48	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	25.79	5.61	8.97	4.49	1.12	0.00	3.36	3.36
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	23.53	13.36	7.63	3.82	4.45	0.00	2.54	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.73	6.04	5.24	1.21	0.40	0.00	1.21	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	6.54	4.36	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	12.67	5.07	0.00	0.00	0.00	0.00	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	10.92	9.71	3.64	1.21	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	31.63	9.04	4.52	0.00	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	11.53	6.59	8.24	4.12	0.82	0.00	3.29	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	34.92	12.70	8.33	3.37	0.99	0.79	0.20	0.60
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	23.69	13.63	9.09	1.62	0.97	0.97	1.62	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	30.56	11.20	7.13	2.04	1.02	0.00	3.06	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	51.84	18.57	10.06	3.09	1.55	0.77	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	53.86	27.88	6.85	1.42	4.25	2.36	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	51.66	72.98	16.91	3.48	3.24	2.09	2.32	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	42.74	12.82	0.00	0.00	4.27	4.27	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	47.37	20.55	7.40	3.19	0.82	2.36	1.44	1.23
mesothelioma cell line:Mero-25	10850-111F4	12.03	11.57	2.72	2.50	0.45	0.68	0.91	0.00
mesothelioma cell line:Mero-41	10851-111F5	40.09	20.05	7.33	3.18	2.44	3.18	2.69	0.49
mesothelioma cell line:Mero-48a	10852-111F6	31.66	20.59	7.97	3.10	0.66	2.44	1.77	1.33
mesothelioma cell line:Mero-82	10853-111F7	27.86	23.65	7.10	4.20	1.58	1.05	2.89	0.53
mesothelioma cell line:Mero-83	10854-111F8	36.26	29.96	6.30	4.26	0.85	1.70	2.38	1.19
mesothelioma cell line:Mero-84	10855-111F9	8.85	10.87	0.76	1.52	0.51	0.76	0.25	0.00
mesothelioma cell line:Mero-95	10856-111G1	28.16	18.22	4.14	3.31	1.45	1.04	1.66	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	20.87	17.39	2.65	3.15	0.50	0.83	1.82	0.17
mesothelioma cell line:NCI-H226	10846-111E9	27.15	26.06	3.62	2.71	1.45	1.99	0.54	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	37.75	34.85	6.15	2.22	1.20	1.54	2.39	1.02
mesothelioma cell line:NCI-H28	10845-111E8	45.55	26.72	17.05	3.31	2.54	2.04	2.04	1.02
mesothelioma cell line:No36	10857-111G2	20.22	15.66	2.28	2.28	0.98	0.98	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	26.01	22.22	5.96	3.79	0.54	0.27	1.08	0.54
migratory langerhans cells, donor1	11901-125F2	74.85	24.57	7.10	1.73	1.54	0.96	1.34	0.38
migratory langerhans cells, donor2	11902-125F3	65.94	16.73	7.08	1.71	1.34	1.95	0.24	0.61
migratory langerhans cells, donor3	11903-125F4	81.13	26.20	13.82	2.51	1.62	1.97	0.72	0.90
mixed mullerian tumor cell line:HTMMT	10689-109F5	29.71	26.44	11.75	6.20	2.61	0.00	4.57	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	18.44	14.84	5.72	1.48	2.12	0.21	1.91	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	23.27	25.80	10.14	5.53	4.61	0.46	1.15	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	44.34	28.92	5.90	2.85	3.43	2.28	0.76	1.52
myelodysplastic syndrome cell line:SKM-1	10772-110F7	55.25	69.67	15.15	8.87	9.98	1.29	2.40	1.29
myeloma cell line:PCM6	10474-106I6	32.62	32.62	7.12	3.36	5.14	0.59	1.78	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	22.32	10.65	6.09	2.54	1.01	0.51	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	30.21	28.44	6.28	2.94	0.98	0.98	1.18	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	24.18	10.70	8.25	3.23	2.45	1.00	0.00	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	25.00	7.65	5.88	1.99	1.40	1.54	0.07	0.74
nasal epithelial cells, donor2	12227-129F4	24.84	10.49	3.31	1.66	0.00	2.21	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	75.69	55.67	27.38	15.87	10.35	0.69	1.61	0.92
neuroblastoma cell line:NB-1	10539-107G8	49.95	33.30	18.33	10.29	4.12	1.31	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	43.86	86.46	24.46	13.50	7.38	1.27	5.69	2.74
neuroblastoma cell line:NH-12	10555-107I6	62.61	67.65	22.73	9.88	11.55	0.75	2.42	2.42
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	49.58	72.12	30.36	24.91	8.54	3.32	9.49	3.08
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	53.37	73.01	24.07	9.34	4.59	1.11	3.64	3.33
neuroectodermal tumor cell line:TASK1	10774-110F9	47.30	60.78	23.75	8.45	6.24	2.62	5.43	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	41.32	27.97	32.42	10.81	3.18	2.54	1.91	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	32.21	19.16	14.91	5.06	0.53	1.06	0.00	2.13
neutrophil PMN, donor1	12133-128D9	74.37	0.00	133.87	0.00	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	26.56	39.84	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	37.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	121.26	259.26	69.51	29.26	35.68	1.35	7.44	4.90
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	26.42	29.62	9.61	4.80	0.80	1.60	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	30.78	22.12	10.90	3.53	1.60	0.96	2.24	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	39.94	16.55	5.52	3.15	0.53	1.58	1.05	1.58
nucleus accumbens, adult, pool1	10037-101F1	65.05	40.96	22.12	4.87	6.28	3.09	0.47	0.37
occipital cortex - adult, donor10196	10172-103C1	92.72	32.97	41.21	8.24	0.00	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	86.68	78.09	33.28	10.20	5.64	4.03	6.71	1.61
occipital cortex, newborn, donor10223	10355-105E4	60.05	17.83	16.38	10.55	2.18	4.73	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	51.69	31.49	20.73	4.46	6.30	1.84	8.40	0.52
occipital lobe, fetal, donor1	10073-102A1	72.09	48.49	50.63	15.88	9.44	2.57	17.16	1.29
occipital pole, adult, pool1	10036-101E9	38.79	30.20	12.85	2.29	3.55	1.66	0.08	0.00
olfactory region, adult	10195-103E6	45.28	34.39	20.44	4.20	4.59	2.29	3.63	1.34
optic nerve, donor1	10277-104E7	62.03	38.02	58.03	10.01	4.00	2.00	6.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	42.83	39.18	11.28	7.40	3.30	3.65	1.25	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	45.89	27.34	9.34	2.47	2.34	1.24	0.27	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	28.45	27.94	5.76	4.06	2.03	1.69	3.22	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	31.07	28.07	8.78	5.43	2.43	0.81	1.16	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	35.86	16.17	6.17	4.70	2.06	2.35	0.59	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	56.06	31.77	9.34	5.61	1.87	0.00	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	75.71	54.71	30.11	17.60	7.85	2.12	1.48	0.64
ovary, adult, pool1	10020-101D2	43.68	21.14	10.66	5.07	3.93	1.22	0.52	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	29.33	17.05	15.95	3.30	1.83	1.83	0.92	0.92
pancreas, adult, donor1	10049-101G4	18.81	35.74	10.35	3.76	3.76	0.94	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	30.19	27.39	18.73	13.42	5.87	0.56	1.40	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	27.60	24.53	6.30	2.90	1.87	0.68	3.58	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	47.85	23.68	8.94	2.65	2.48	1.32	0.83	0.66
paracentral gyrus, adult, pool1	10035-101E8	57.84	42.28	20.87	4.21	5.67	2.93	0.37	0.09
parietal cortex, adult, donor10258	10373-105G4	57.25	12.48	25.69	2.20	0.00	6.61	4.40	0.73
parietal lobe - adult, donor10196	10171-103B9	68.66	28.21	23.51	4.70	2.82	2.82	5.64	1.88
parietal lobe, adult, donor10252	10157-103A4	73.25	51.88	22.80	7.13	2.57	2.85	6.84	0.57
parietal lobe, adult, pool1	10034-101E7	54.19	39.83	20.18	5.46	5.29	3.08	0.18	0.35
parietal lobe, fetal, donor1	10072-101I9	68.86	62.07	39.76	18.43	10.67	2.91	9.70	1.94
parietal lobe, newborn, donor10223	10356-105E5	49.72	14.21	11.22	8.60	1.50	1.50	1.12	1.12
parotid gland, adult	10199-103F1	32.68	16.03	9.25	3.08	1.23	0.62	1.85	0.62
penis, adult	10200-103F2	50.49	30.08	16.11	3.76	6.98	1.61	4.30	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	64.71	35.33	19.34	11.34	5.39	2.60	0.93	3.53
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	18.79	16.03	5.97	2.33	1.46	1.02	1.46	0.29
pineal gland - adult, donor10196	10179-103C8	54.18	18.06	42.57	1.94	5.16	2.58	6.45	0.65
pineal gland, adult, donor10252	10160-103A7	117.85	53.30	71.66	9.48	2.96	1.78	2.96	0.00
pineal gland, adult, donor10258	10377-105G8	55.18	15.68	20.07	2.51	3.14	4.39	6.90	1.25
pituitary gland - adult, donor10196	10180-103C9	81.96	57.67	86.00	19.22	9.11	4.05	6.07	3.04
pituitary gland, adult, donor10252	10162-103A9	113.62	87.04	93.29	32.31	14.59	4.69	6.25	1.04
pituitary gland, adult, donor10258	10378-105G9	64.69	37.45	36.60	14.47	5.11	2.55	8.51	1.70
placenta, adult, pool1	10021-101D3	59.66	30.32	9.14	2.58	1.40	1.40	0.43	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	45.55	60.39	18.41	11.52	5.96	2.65	3.05	1.32
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	39.22	54.01	16.81	6.23	4.20	2.80	1.87	0.93
pons, adult, pool1	10033-101E6	66.36	42.86	19.02	4.73	3.70	4.48	0.52	0.43
postcentral gyrus, adult, pool1	10032-101E5	43.67	35.13	17.35	3.57	4.45	2.01	0.17	0.44
promyelocytes/myelocytes PMC, donor1	12132-128D8	41.83	104.57	148.49	39.74	16.73	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	33.05	11.02	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	46.76	28.55	5.83	2.48	3.06	3.93	3.20	0.58
prostate cancer cell line:PC-3	10439-106E7	47.19	38.66	11.25	3.63	4.72	2.00	3.09	2.18
prostate, adult, pool1	10022-101D4	46.07	32.29	13.33	5.44	5.17	1.45	0.54	0.27
putamen, adult, donor10196	10176-103C5	72.94	44.85	27.38	5.90	5.90	4.49	3.78	1.18
putamen, adult, donor10252	10152-102I8	80.39	41.18	17.65	9.80	5.88	5.88	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	43.71	26.23	10.93	0.00	0.00	3.28	4.37	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	56.05	26.58	17.15	4.11	3.14	2.42	5.80	0.72
putamen, newborn, donor10223	10365-105F5	68.22	23.24	17.24	14.24	0.75	6.00	0.75	1.50
rectal cancer cell line:TT1TKB	10469-106I1	40.44	46.26	17.75	9.02	7.56	1.45	0.58	0.29
rectum, fetal, donor1	10067-101I4	58.42	65.38	37.56	9.74	4.17	1.39	4.17	4.17
renal cell carcinoma cell line:OS-RC-2	10411-106B6	44.10	51.09	11.87	2.76	3.60	1.48	0.85	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	25.68	59.23	10.36	5.38	7.46	2.90	5.38	1.66
retina, adult, pool1	10030-101E3	45.13	44.73	27.73	7.55	8.25	1.09	0.00	0.40
retinoblastoma cell line:Y79	10475-106I7	48.58	79.24	24.68	7.53	10.65	2.60	3.38	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	44.38	46.72	12.54	4.55	2.58	1.48	1.97	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	83.24	67.21	25.03	9.84	5.34	1.97	1.97	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	46.23	20.46	9.85	4.55	0.76	2.27	0.00	1.52
salivary acinar cells, donor1	11771-123I7	33.99	33.99	9.39	3.72	3.88	1.62	2.27	0.49
salivary acinar cells, donor2	11772-123I8	41.03	34.28	11.70	4.96	2.48	2.75	2.48	0.55
salivary acinar cells, donor3	11773-123I9	37.74	21.85	17.21	4.63	4.63	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	29.17	26.31	17.16	4.00	2.86	1.72	0.57	1.72
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	61.29	27.57	9.19	3.71	5.82	2.87	1.85	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	53.96	26.57	10.81	3.76	4.58	1.18	1.53	0.71
seminal vesicle, adult	10201-103F3	50.26	41.80	35.98	10.58	4.23	1.06	4.76	3.70
serous adenocarcinoma cell line:JHOS-2	10639-108I9	38.38	55.63	20.65	13.12	3.16	1.94	2.92	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.11	6.29	3.27	1.26	0.75	0.75	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	18.06	13.05	2.01	0.00	0.00	1.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	24.04	31.03	9.40	4.30	1.48	3.36	2.55	0.94
signet ring carcinoma cell line:Kato III	10436-106E4	27.96	37.58	6.30	2.21	2.76	1.77	0.44	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	31.35	32.39	8.00	2.58	3.35	1.16	0.65	0.52
skeletal muscle - soleus muscle, donor1	10282-104F3	32.63	21.28	30.50	5.67	3.55	0.71	8.51	1.42
skeletal muscle, adult, pool1	10023-101D5	44.50	14.75	8.28	2.64	1.92	0.60	0.72	0.36
skeletal muscle, fetal, donor1	10066-101I3	18.09	10.05	14.07	5.03	3.02	0.00	4.02	0.00
skin, adult, donor1	10074-102A2	27.14	13.57	13.57	0.00	6.79	0.00	20.36	0.00
skin, fetal, donor1	10065-101I2	56.18	49.87	38.50	3.79	1.26	1.26	11.99	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	22.01	21.35	8.00	5.67	3.67	2.33	0.67	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	53.90	88.89	29.00	18.28	3.78	2.52	11.66	1.58
small cell lung carcinoma cell line:DMS 144	10841-111E4	63.22	103.31	41.06	10.60	13.69	1.54	3.08	4.05
small cell lung carcinoma cell line:LK-2	10541-107H1	64.61	41.54	19.78	8.90	5.44	2.31	0.66	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	57.26	58.71	78.82	27.99	15.92	6.11	7.40	2.41
small cell lung carcinoma cell line:WA-hT	10562-108A4	50.77	75.62	23.75	11.99	7.63	4.14	3.27	2.62
small intestine, adult, pool1	10024-101D6	50.05	35.95	14.93	4.78	4.30	1.43	1.79	0.84
small intestine, fetal, donor1	10064-101I1	31.20	24.57	14.25	7.62	3.44	1.23	5.65	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	34.36	56.42	24.11	6.15	3.08	4.62	3.59	2.05
smooth muscle, adult, pool1	10048-101G3	43.68	36.18	14.99	3.36	5.69	0.78	3.36	1.55
somatostatinoma cell line:QGP-1	10781-110G7	31.09	36.72	36.45	9.38	4.29	1.34	0.80	0.27
spinal cord - adult, donor10196	10181-103D1	53.22	24.55	17.66	7.57	3.90	1.61	7.80	0.69
spinal cord, adult, donor10252	10159-103A6	87.13	49.28	20.11	7.89	5.52	3.55	2.37	0.79
spinal cord, adult, donor10258	10369-105F9	60.88	10.38	13.14	2.08	0.00	3.46	2.77	0.00
spinal cord, fetal, donor1	10056-101H2	50.62	36.59	23.78	10.98	3.05	1.83	4.27	0.00
spinal cord, newborn, donor10223	10359-105E8	61.53	17.91	17.45	7.35	4.59	3.21	3.21	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	30.02	16.58	7.17	1.94	0.90	2.99	1.79	0.30
spleen, adult, pool1	10025-101D7	38.88	28.63	8.59	3.85	3.19	0.33	0.55	0.22
spleen, fetal, pool1	10044-101F8	40.60	50.06	15.81	8.82	5.56	0.79	0.08	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	36.13	32.71	13.35	4.35	3.83	1.35	1.76	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	37.22	30.57	6.84	3.42	2.28	1.90	0.19	1.14
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	33.55	37.74	9.09	3.15	3.84	1.40	4.89	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	22.28	22.28	12.90	7.43	0.39	0.00	0.78	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	40.52	33.43	23.75	10.13	3.71	2.48	1.69	1.58
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	22.03	18.21	2.12	4.66	0.42	1.27	1.69	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.92	19.04	1.27	3.81	1.27	2.54	2.54	0.42
stomach, fetal, donor1	10062-101H8	68.35	60.87	50.19	8.54	3.20	1.07	1.07	3.20
submaxillary gland, adult	10202-103F4	42.73	37.60	23.36	7.98	5.70	2.85	2.85	0.57
substantia nigra - adult, donor10196	10178-103C7	162.82	54.27	162.82	54.27	0.00	0.00	814.11	162.82
substantia nigra, adult, donor10252	10158-103A5	78.72	76.02	23.06	6.85	6.65	1.87	4.78	2.28
substantia nigra, adult, donor10258	10371-105G2	51.21	7.24	14.48	3.10	0.52	4.14	1.55	1.03
substantia nigra, newborn, donor10223	10358-105E7	44.51	14.13	12.72	7.07	2.12	2.83	2.83	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	59.15	45.17	9.86	3.90	2.75	0.46	4.59	1.60
temporal lobe, adult, pool1	10031-101E4	38.49	34.33	16.62	3.56	3.48	2.37	0.08	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	51.28	34.19	52.00	7.12	9.97	3.56	14.96	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	53.18	37.80	39.56	10.11	4.83	2.20	3.96	1.76
tenocyte, donor1	11763-123H8	30.72	23.04	12.22	2.79	0.35	1.05	2.09	1.75
tenocyte, donor2	11765-123I1	32.05	18.69	7.63	2.29	1.14	0.38	2.29	2.29
tenocyte, donor3	11768-123I4	30.77	21.50	11.12	2.59	1.48	1.11	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	82.43	83.45	59.32	27.87	9.86	3.06	5.78	1.19
teratocarcinoma cell line:NCR-G1	10798-110I6	32.53	31.75	7.40	5.55	2.16	0.31	0.92	0.31
teratocarcinoma cell line:PA-1	10807-111A6	46.65	19.99	31.93	4.96	1.55	1.08	3.25	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	38.34	49.64	72.87	40.24	7.49	2.03	4.19	2.54
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	92.27	79.04	87.36	47.27	11.35	3.40	6.81	2.65
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	19.09	27.05	55.84	31.85	5.45	0.33	1.42	1.64
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	51.79	35.18	43.97	22.80	3.58	0.65	5.21	1.30
testis, adult, pool1	10026-101D8	54.76	23.19	15.57	4.51	7.09	4.29	0.54	1.18
testis, adult, pool2	10096-102C6	60.90	51.87	38.34	16.69	11.73	9.92	4.06	1.80
thalamus - adult, donor10196	10168-103B6	87.21	38.64	30.91	0.00	2.21	6.62	7.73	1.10
thalamus, adult, donor10252	10154-103A1	72.52	68.92	20.79	6.88	5.78	4.22	5.16	1.88
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	21.55	10.78	1.54	1.54	6.16	3.08	3.08
thalamus, adult, donor10258, tech_rep2	10370-105G1	34.58	12.52	11.53	4.45	3.13	1.81	1.98	1.65
thalamus, newborn, donor10223	10366-105F6	46.60	9.78	7.48	9.78	1.15	3.45	2.30	0.00
throat, adult	10209-103G2	45.44	36.20	19.97	7.24	4.49	0.75	3.50	0.75
throat, fetal, donor1	10061-101H7	54.85	52.10	33.52	11.58	7.01	1.83	6.40	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	42.73	59.22	23.85	9.14	2.78	2.19	3.58	1.59
thymus, adult, pool1	10027-101D9	69.79	55.87	13.62	10.64	8.35	1.49	0.50	0.30
thymus, fetal, pool1	10043-101F7	89.57	105.26	29.72	17.87	14.75	1.66	1.04	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	30.05	17.95	3.99	1.86	0.40	1.99	0.27	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	29.34	28.50	14.11	3.77	3.21	0.28	1.96	0.70
thyroid, adult, pool1	10028-101E1	53.75	37.33	16.52	4.11	5.51	2.61	0.47	0.37
thyroid, fetal, donor1	10060-101H6	44.82	43.24	31.64	5.27	5.54	1.58	5.27	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	40.04	24.64	15.40	6.16	0.00	6.16	6.16
tongue, adult	10203-103F5	33.96	20.47	11.63	4.19	2.09	0.93	1.16	0.70
tongue, fetal, donor1	10059-101H5	41.77	18.52	7.88	2.76	3.94	0.00	1.18	0.39
tonsil, adult, pool1	10047-101G2	39.07	63.51	16.23	6.81	7.51	0.80	0.30	0.50
trachea, adult, pool1	10029-101E2	39.92	30.51	12.19	3.44	3.03	0.82	0.33	0.25
trachea, fetal, donor1	10058-101H4	40.39	41.55	26.93	13.08	4.23	0.77	4.62	3.08
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	34.01	13.46	7.79	2.13	1.77	2.83	2.13	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	55.93	38.10	14.79	3.85	3.75	2.33	0.71	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	77.72	55.94	25.70	10.34	8.15	1.41	8.30	3.29
tridermal teratoma cell line:HGRT	10694-109G1	43.76	13.32	19.03	1.90	1.90	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	26.33	27.17	5.59	3.13	3.98	0.51	1.35	0.25
umbilical cord, fetal, donor1	10057-101H3	47.99	29.21	4.17	4.17	0.00	6.26	2.09	0.00
uterus, adult, pool1	10100-102D1	67.06	37.20	31.91	8.36	7.34	1.54	0.34	1.02
uterus, fetal, donor1	10055-101H1	62.46	44.03	21.50	10.24	4.61	1.02	4.10	1.54
vagina, adult	10204-103F6	47.82	30.37	5.17	7.11	3.88	2.58	0.00	0.00
vein, adult	10191-103E2	39.46	35.51	10.74	7.01	5.04	0.44	1.75	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	25.37	26.17	11.22	2.67	3.20	0.53	2.67	1.34